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“Reality is frequently inaccurate.” 
The Hitchhikers Guide to the Galaxy, Douglas Adams 
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1. Summary 
 
 
Major issues in both toxicological as well as pharmaceutical research are biological 
barriers, impeding the invasion of pathogens but also the delivery of beneficial substances 
into the body. The upper lungs as site of application of such substances exhibit a 
particularly efficient biological barrier: the mucus blanket and its mucociliary clearance. 
The fate of particles upon deposition onto the moving mucus barrier is yet unsolved and 
was central theme of this work. In this context, mucociliary clearance of nanoparticles and 
its fluid dynamics were investigated. These results were correlated with the analysis of 
microscopic and macroscopic particle penetration behavior in mucus and mucus structure. 
Here, the application of complex methods such as cryoscopic scanning electron 
microscopy (cryo-SEM), atomic force microscopy (AFM) and optical tweezers revealed 
the mechanisms of particle mobility in mucus. It could be shown that mucociliary 
clearance is independent on particle properties such as size, shape, charge or surface 
chemistry. It was demonstrated that this is due to the only poor particle mobility in mucus: 
The polymer scaffold of mucus is highly rigid which, in combination with the extensive 
heterogeneity in pore size, impedes particle translocation. In contrast to model gels and due 
to this rigidity, particles in mucus which are exposed to external force fields cannot deform 
or rupture the polymer scaffold of mucus. 
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2. Zusammenfassung 
 
 
Ein zentrales Thema sowohl in der toxikologischen als auch der pharmazeutischen 
Forschung sind biologische Barrieren, welche die Aufnahme von Krankheitserregern aber 
auch Pharmazeutika in den Körper erschweren. Die obere Lunge als Applikationsort 
solcher Substanzen weist eine besonders effiziente biologische Barriere auf: die Mukus-
Schicht mit ihrer mukoziliären Clearance. Das Schicksal von Partikeln nach deren 
Deposition auf der bewegten Mukus-Schicht ist noch ungeklärt und war zentrales Thema 
dieser Arbeit. In diesem Kontext wurde die mukoziliäre Clearance von Nanopartikeln und 
deren Fluid Dynamik untersucht. Die Ergebnisse wurden mit der Analyse des mikro- und 
makroskopischen Penetrationsverhaltens von Partikeln in Mukus und dessen Struktur 
korreliert. Dabei deckte die Anwendung von Kryo-Elektronenmikroskopie, 
Rasterkraftmikroskopie und der optischen Pinzette die Mechanismen der Partikelmobilität 
in Mukus auf. Zusammenfassend konnte gezeigt werden, dass die mukoziliäre Clearance 
unabhängig von Partikelgröße, -form, -ladung, oder -oberflächenchemie ist. Es wurde 
nachgewiesen, dass dies auf die vernachlässigbare Partikelmobilität in Mukus 
zurückzuführen ist: Das Polymergerüst von Mukus ist hoch rigide, was aufgrund der 
großen Heterogenität der Porengröße die Partikeltranslokation behindert. Im Gegensatz zu 
den verwendeten Modell-Gelen und aufgrund dieser Rigidität können Partikel, die einem 
externen Kraftfeld ausgesetzt sind, das Polymergerüst von Mukus nicht zerstören. 
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3.1 Pulmonary Drug Delivery and Nanocarriers 
 
The pulmonary route to deliver drugs is one of the earliest forms of drug administration to 
treat diseases (Bailey and Berkland, 2009). Not considering the use of “vapors” by 
Egyptians in 1500 B.C., such applications even date as early as the late 17th century when 
Bennet used inhalation treatments to cure tuberculosis (Patton and Byron, 2007). With 
growing technological knowledge, inhalation made its way into the 20th century and 
became a convenient and effective treatment in various therapies. By now, inhalation of 
drugs as droplet aerosol or dry powder is used not only in local but also systemic 
applications. While the former has played a more important role in the beginning of 
inhalation therapy (asthma, tuberculosis and obstructive disorders), the latter is already 
being exploited in various diseases (e.g. insulin delivery) with more applications still to 
come. The advantages of pulmonary delivery, grasped only empirically in the beginning, 
are now being widely appreciated in particular with respect to the delivery of modern 
formulations: Crucial for any type of drug delivery application is the performance in 
uptake/absorption, stability and retention, i.e. the (time dependent) concentration in the 
blood of the delivered active pharmaceutical ingredient (API) in comparison to intravenous 
application which can be summarized by the term “bioavailability”. Not only in this 
respect, the pulmonary route holds great potential: The large surface area, high epithelial 
permeability and low catabolic enzymatic activity allow for rapid and effective uptake of 
drugs. In addition, it has the specific advantage of avoiding first-pass effects and potential 
side-effects of high systemic concentrations typical of conventional delivery methods 
(Bailey and Berkland, 2009). Furthermore, the convenience and adherence of such a form 
of delivery versus oral dosage forms or even injections are highly relevant in clinical 
practice or pediatrics. Especially with respect to therapies or vaccination in third world 
countries, where injections pose a major risk to infections, this aspect is particularly 
important.  
In the past, the focus of research in aerosol medicine has been laid on the optimization of 
drug carrier deposition in the lungs. Here, implications of physical and aerodynamic 
properties of such carriers and of the design of inhalation devices on the deposited particle 
or droplet fraction had to be thoroughly understood to control deposition in the desired 
way. Especially particle size distribution and the respective size-associated deposition 
mechanisms (impaction, sedimentation and diffusion) were extensively investigated: In 
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particular in terms of systemic delivery, it is often desired to deposit particles in the deeper 
lungs where the large surface area and thin epithelium enhance drug uptake. To advance 
this deep into the lungs, the aerosol needs a certain particle/droplet size distribution to 
avoid deposition or impaction in the upper parts of the lungs. Particles with aerodynamic 
diameters of approximately 1-5 µm are considered ideal for alveolar deposition (Scheuch, 
Kohlhaeufl et al., 2006). Above and below this size, particles or droplets are preferably 
deposited in the trachea or bronchia (figure 1). However, new technologies such as larger 
carriers doped with nanoparticles which can be released after deposition are applied to 
overcome these aerodynamic restriction. Thus, it is possible to combine existing 
knowledge of optimal aerosolization and thus deposition patterns with the advantages of 
the more recent concept of nanocarriers. In current opinion, these nanoparticles are objects 
with at least one dimension < 100 nm (Oberdorster, Oberdorster et al., 2005) while in the 
pharmaceutical context, this is often extended to particulate matter of several hundred 
nanometers in size (Kreuter, 1991).  
 
 
Figure 1: Particle deposition in dependency of particle size (aerodynamic diameter). Particles of an 
aerodynamic diameter between 1 and 5 µm are considered ideal for alveolar deposition whereas smaller and 
larger particles are preferably deposited in the airways or the mouth and throat, respectively. By courtesy of 
Christian Ruge, adopted from (Patton and Byron, 2007).  
 
One key feature of these benefits of the application of nanoparticles is linked with the 
mentioned term of bioavailability: In current research, the development of new 
applications for systemic delivery, mostly involving fragile and costly (macro)molecules or 
proteins, demands more than an optimal particle or droplet deposition as stability and 
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delivered amount are much more restricted than in conventional drugs. Therefore, in this 
case, an optimization of dissolution properties, stability and targeting is enormously more 
important. These factors can be positively influenced by the use of nanocarriers. The small 
size and thus the surface area of these particles greatly improves dissolution behavior even 
without the use of enhancers with often unknown long-term safety (Bailey and Berkland, 
2009). Furthermore, it is widely accepted that smaller particles (< 0.5 µm) may be taken up 
in a more effective way by cells than larger particles (Koch, Reynolds et al., 2005; Bailey 
and Berkland, 2009). This may be the reason that nanoparticles exhibit prolonged retention 
compared to micoparticles (Geiser and Kreyling, 2010). These uptake properties also 
provide the potential to improve the targeting to specific cell types or intracellular 
compartments.  
One big issue in the characterization of the potential of nanocarriers in terms of 
bioavailability refers to the aspects of retention and penetration. Retention describes the 
performance of a formulation in resisting the respective forms of clearance characteristic 
for the site of delivery. For intravenous delivery the prominent forms are typically the renal 
and hepatic clearance. In pulmonary delivery, however, this refers mainly to the 
mucociliary- and the macrophage clearance. Mucociliary clearance is the dominant form of 
clearance in the central and upper lungs whereas macrophage clearance is more dominant 
in the alveoli. Penetration is important, as the thick mucus layer in the upper lungs 
(figure 2) is not only excreting deposited particles by mucociliary clearance but forms a 
compact non-epithelial barrier which nanocarriers have to cross before reaching the 
epithelium or even the blood stream. The work presented here, focuses on the local 
pulmonary delivery in the upper lungs as it is relevant for diseases such as chronic 
obstructive pulmonary disease (COPD) or pulmonary hypertension where frequent and 
long-lasting local treatment is necessary. Here, the need for modern formulations with 
sustained, local release, and thus a minimized drug or carrier clearance, is paramount. 
Therefore, mucociliary clearance and mucus penetration which have been under 
investigation for quite some time but are not sufficiently understood so far, are very 
important in this field, particularly for nanoparticle delivery. Here several mechanisms are 
exclusive for such small carriers (e.g. wetting phenomena and fluid dynamics) and have to 
be thoroughly considered to evaluate the pharmaceutical potential of the carrier. 
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3.2 Mucus and Mucociliary Clearance 
 
Mucociliary clearance is an innate airway defense mechanism enabling the body to excrete 
foreign material in a very efficient way. The underlying principle is the constant secretion 
of mucus and its fast cranial propulsion (3-25 mm/min in humans (Hofmann and 
Asgharian, 2003; Antunes and Cohen, 2007)) by the concerted action of beating cilia 
attached to the tips of the epithelial cells (figure 2). Thus, airborne pathogens, dust or other 
foreign material can be trapped inside the mucus layer and removed from the airways. 
Mucus is a complex fluid consisting of proteins, electrolytes and water. As biological 
hydrogel, the water content is very high (95 % by weight). The macromolecular hydrogel 
structure is given by mucins (< 5 % by weight). The remaining components are inorganic 
salts, carbohydrates and lipids (Peppas and Huang, 2004). Mucins are large proteins 
containing highly hydrophilic glycosylated regions as well as “naked” and thus more 
hydrophobic domains. The sugar content usually represents up to 50 % of the protein 
weight where the sugar chains are attached via O-glycosidic bounds between N-
acetylgalactosamine and serine or threonine residues (Sanders, Rudolph et al., 2009); 
further sugar residues are galactose, fucose and sialic acids. The dominating amino acids in 
the protein backbone are serine, threonine and proline (Peppas and Huang, 2004). The 
typical monomer length is 500 nm with a weight of 2-16 MDa (Sanders, Rudolph et al., 
2009). Each mucosal surface has its own characteristic mucin composition: in pulmonary 
mucus, MUC5AC and MUC5B are the most abundant mucins (Thornton and Sheehan, 
2004). 
The hydrogel structure of mucus is given by polymerization of these mucin monomers to 
form block copolymers. Here, mucin monomers are linked by disulfide bridges, physical 
entanglement or hydrophobic interactions between non-glycosylated domains (Thornton 
and Sheehan, 2004; Cone, 2009). The underlying principles of mucin polymerization, 
especially with regard to the formation of the complex structure of the different layers of 
the pulmonary mucosa remain yet unsolved. One of the more established models for the 
formation of the mucin hydrogel is the so called “jack-in-the-box” model, describing the 
formation of the gel by quick hydration of the mucins upon secretion in a condensed and 
non- or only less hydrated form (Verdugo, Deyrup-Olsen et al., 1987; Verdugo, 1991). 
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Figure 2: The lungs are lined with different non-epithelial barriers. In the peripheral lungs, the epithelium is 
lined with a very thin layer of surfactant. In the upper lungs, the epithelium is additionally covered with a 
thick barrier composed of the pericilary layer (PCL) of low viscosity and the highly viscoelastic “tenacious” 
(Florey, 1962) mucus layer. 
 
 
This mechanism is also believed to contribute to the formation of the distinct two layer 
structure of the pulmonary mucosa: The epithelium of the upper lungs is lined with cells 
bearing 50-200 cilia per cell (Antunes and Cohen, 2007) which beat in a coordinated way 
to transport the mucus layer resting on the tips of these cilia. The cilia itself are moving in 
a layer of different properties, the periciliary layer (PCL). The PCL is located beneath the 
mucus blanket and is thought to be established by a gradient in mucin concentration 
proportional to the distance from the epithelium. Recent findings support the hypothesis of 
the PCL being interfused with tethered mucins, giving it some internal structure (Randell 
and Boucher, 2006). These more or less distinct layers differ mainly in rheological 
properties. Whereas the several micron thick mucus layer (0.2-30 µm (Sims and Horne, 
1997; Widdicombe, 2002; Sanders, Rudolph et al., 2009)) is a gel of quite high viscosity, 
the underlying PCL is of lesser viscosity, believed to thus enable efficient ciliary beating. 
This difference in rheology is considered to be due to complex interactions between 
hydration status regulated by ion transporters, a gradient in mucin concentration and 
adaptation to environmental factors and mechanical stress (Tarran, Trout et al., 2006; 
Button and Boucher, 2008). The height of the PCL of approximately 7 µm (Button and 
Boucher, 2008) is given by the length of the cilia and is a key factor in the investigation of 
diseases such as cystic fibrosis (CF) which is associated with a defect in ion transport 
pathways affecting the volume of the PCL, the efficient ciliary beating and thus an 
impaired mucociliary clearance, leading to increased bacterial invasion. The thin layer (on 
average 200 nm (Bastacky, Lee et al., 1995)) of pulmonary surfactant (mainly composed of 
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phospholipids and proteins) on top of the mucus blanket has its major function in the 
deeper lungs, where it is the only non-epithelial barrier and contributes to the structural 
stability of the alveoli and immunological homeostasis. 
 
 
 
Figure 3: Metachronal fields describe areas of homogeneous mucus transport direction (blue arrows). The 
size of the field can differ over a large size range and is also different in healthy or diseased state (Iravani and 
Melville, 1976). 
 
 
The beating pattern of the cilia is organized in so-called “metachronal fields” (Iravani and 
Melville, 1976) referring to the slight variance in space and time in the beating pattern of 
the cilia: The direction and the phase of the beating cycle (9-15 Hz in humans (Antunes 
and Cohen, 2007)) can be divergent in neighboring areas of the mucus blanket (figure 3). 
The areas of homogeneous transport direction and velocity are called metachronal fields.  
While mucus clearance direction is heterogeneously organized in the horizontal (x-y) 
plane, other features of mucociliary clearance depend on the vertical position and thus the 
height above the epithelium. So far, the beating cycle of the cilia and the physical 
implications on mucus flow (fluid dynamics) are not completely solved. In the past years 
large efforts were focused on the mathematical modeling of the ciliary beating cycle 
(Barton and Raynor, 1967; Fulford and Blake, 1986; Smith, Gaffney et al., 2007), the 
complexity of the models and the results of this modeling approach clearly depending on 
the computing resources of the respective period. However, with only marginal 
experimental counterweight, these results show high variation, in particular for mucus flow 
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profiles, describing the velocity of the mucociliary transport in dependency of the height 
above the epithelium (Smith, Gaffney et al., 2008).  
Similar to the (mathematical) description of the ciliary beating cycle, the interaction of 
particles with the mucus blanket and their mucociliary clearance has attracted much 
attention in the last years. Here, the focus was clearly laid on epidemiological or 
toxicological considerations, in particular with respect to pollution and exhaust, asbestos or 
the potential risk of exposure to newer materials such as carbon nanotubes. Therefore most 
of the data is acquired via szintigraphic or similar ensemble averaged methods, giving 
insight into the overall distribution or the cleared fraction of an inhaled particle species 
(Moller, Felten et al., 2008; Geiser and Kreyling, 2010). Parameters under investigation 
were particle size, shape and material, exposure and clearance time. Although it seems that 
there is consensus on the point that particle translocation through mucus and uptake into 
the blood stream is a minor clearance pathway compared to macrophage uptake and 
mucociliary clearance (Geiser and Kreyling, 2010), those studies do not give insight into 
the underlying mechanism of particle deposition onto and translocation within the mucus 
blanket on the single particle level. The investigation of the last point was previously 
assessed by microscopic methods to describe particle translocation phenomena in vivo. 
Here, large particles (> 10 µm) were observed to translocate into the pulmonary 
epithelium, which was concluded to be mainly due to wetting forces of the pulmonary 
surfactant (Schürch, Gehr et al., 1990; Gehr, Green et al., 1996). However, these results 
cannot be used to judge nanoparticle fate upon deposition onto the mucus blanket 
(figure 4). 
 
 
Figure 4: Particle translocation upon deposition onto the mucus blanket depends on size. Wetting forces can 
maximally submerse small particles completely but not cause further translocation through mucus (A). 
Particles with a diameter approaching the thickness of PCL and mucus, however, can be pushed inside the 
epithelium due to wetting forces (B). 
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In this case, wetting forces may cause a immersion of nanoparticles below the surface of 
the mucus blanket, but do not influence particle mobility inside mucus and thus do not 
cause a translocation through mucus towards the epithelium. This is particularly true if the 
fluid layer on top of the epithelium is several microns thick as it is in the upper lungs. 
Therefore, the fate of nanoparticle upon deposition onto mucus is not sufficiently solved 
yet and satisfying studies are still missing. 
 
 
3.3 Particle Mobility in Mucus and Hydrogels 
 
The non-epithelial barrier of the pulmonary mucus blanket in the upper lungs derives its 
barrier properties not only from the ciliary clearance and thus the fast excretion of inhaled 
material. As mentioned before, the highly viscous and compact mucus layer impedes 
translocation of pathogens or particulate matter to the epithelium. Similar to other 
hydrogels, hydrated mucins in mucus form a tight mesh of entangled fibers, trapping any 
material entering the mucus. In physical terms, this system can be described as complex 
fluid, exhibiting properties of a viscous liquid as well as of an elastic solid. Such 
rheological properties are usually quantified by the two parameters viscosity and elasticity. 
While the former refers to the resistance of the fluid to flow, the latter describes the more 
solid like property of the material stiffness. Both parameters are complex quantities that 
depend on further parameters like temperature, shear rate, shear frequency, time and length 
scale etc. and can therefore only hardly be applied to grasp the complete behavior of such 
systems if evaluated without experimental details and boundary conditions. Nevertheless, 
viscosity and elasticity or derived parameters represent an established measure to describe 
rheological properties of mucus and are given by 
 
.                                                                              (1) 
 
Here, µ* is the complex viscosity with its real and imaginary part µ’ and µ’’ corresponding 
to the viscosity and the elasticity, τ* = shear stress, γ = shear strain and G’ and G’’ 
represent storage and loss modulus respectively; µ is often denoted with the symbol η as 
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well. The viscosity of mucus ranges between 102 and 10-2 Pas (Lai, Wang et al., 2009), 
referring to ten to 100000 times that of water depending on the parameters mentioned 
above as well as disease state and species. 
Not only within one species or even within one individual, the variation in the magnitude 
of the above mentioned parameters is significant, which demonstrates the highly 
heterogeneous nature of this fluid. This heterogeneity impedes general conclusions 
regarding the modeling and prediction of rheological behavior of mucus. It is however 
quite established that any disturbance in the homeostasis of mucus secretion (e.g. in CF) 
affects mucus rheology and thus mucociliary clearance of particles trapped inside the 
mucus blanket. 
Before particles are cleared they make contact with the mucus blanket. Once submersed 
inside this hydrogel, particle mobility within this matrix and the mechanisms influencing 
the extent of this mobility are yet unsolved. Driving forces for a particle translocation into 
or even through this barrier are impaction, gravity, diffusion and external forces such as 
magnetic or electrostatic force fields. The first three of these mechanisms depend mainly 
on particle properties such as impaction trajectory and velocity, particle density, shape and 
size and rheological properties of the fluid. Diffusion behavior in dependency of particle 
properties is of great importance in the investigation of particle mobility in mucus. 
Diffusion in viscous fluids is a complex topic which demands sophisticated mathematical 
models. The most established model for diffusion is given by the Stokes-Einstein equation, 
relating particle size and diffusion constant 
 
           (2) 
 
with D = diffusion constant, kB = Bolzmann constant, T = temperature and r = particle 
radius. The diffusion constant describes how fast a particle diffuses. This can be seen by 
the relation between D and the mean squared displacement (MSD,  ൏ ∆ݎଶሺݐሻ ൐) for three-
dimensional diffusion: 
 
         (3) 
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Here, t represents the correlation time of the experiment while α has the value of 1 in a 
purely viscous fluid but can be different for complex fluids such as mucus or other 
hydrogels. In this case r denotes the distance from the location at the previous time step. 
The MSD is proportional to the width of the probability distribution of particle location 
(figure 5) i.e. it quantifies the probability to diffuse a certain distance within the given 
correlation time t. 
However, as seen in equation 3, in particular for complex fluids, this determination of 
diffusion behavior is strongly dependent on the correlation time t, i.e. the time span for 
which the MSD is measured. Therefore, it is not easy to distinguish between different types 
of diffusion, such as hindered or free diffusion (figure 6) by only considering short 
correlation time spans.  
Although being particularly important concerning the mobility of particles in mucus, this 
strict discrimination is therefore not often addressed in current research. Much more, the 
focus of studies investigating particle-mucus interactions has been laid on the mechanisms 
involved in the restriction of particle mobility. Here, the goal is in the determination of 
particle properties influencing the mobility such as adhesion to mucus or particle size. 
These parameters are important to describe the filtering ability of mucus as being primarily 
a size sieving (Sanders, Rudolph et al., 2009) or interaction filtering (Lieleg and Ribbeck, 
2011) process. While the former model pronounces the sizes of the pores inside mucus or 
other biological hydrogels as limiting factor, the latter favors adhesive interactions between 
particles and gel components. Whatever mechanism will be dominant in the respective 
case, the reason will surely lay within the structure of mucus on the microscale which is -in 
detail- still not clear (Peppas and Huang, 2004). Unfortunately, recent studies relied only 
on microscopic analysis with rather harsh conditions or very indirect methods to clarify 
mucus structure. Therefore, the investigation of the structure of native pulmonary mucus in 
its physiological state is very important to understand particle mobility in mucus and their 
interactions with mucus components such as mucins. 
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Figure 5: The meaning of the MSD can be visualized by plotting the probability of a particle to be located at 
a certain distance from the origin. With increasing time (t1 < t2 < t3) this distribution broadens and the MSD, 
being proportional to the width (full width at half maximum, FWHM) of the distribution, increases. This 
means, the probability to find the particle away from the origin increases (as quantified by the MSD), 
whereas the origin is still the most probable location of the particle. Image by courtesy of Dominik Selzer. 
 
 
 
 
Figure 6: Free (B) and hindered diffusion (A) cannot easily be distinguished by MSD measurement. For 
short correlation times t (highlighted by the box) plateau values for the MSD are not reached, thus showing 
similar behavior for both types of diffusion behavior. 
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3.4 Aim of This Work 
 
As presented in the previous sections, the thick mucus blanket and its clearance by ciliary 
action acts as significant barrier to the translocation of deposited particles down to the 
epithelium and thus the blood stream. The mobility of particles in mucus and the 
dependence of yet unknown parameters or the controllability of the mucociliary clearance 
are largely unexplored. Especially for pharmaceutical purposes intending to maximize such 
translocation, this is of great importance. However, it is not desired to decrease or even 
abort mucociliary clearance, as it is the primary innate defense mechanism in the lungs and 
thus crucial for pulmonary health. Due to the same reason, it is not desired to diminish the 
overall barrier properties of the pulmonary mucus. A much more elegant way to reach 
increased bioavailability of formulations administered via the lungs would be to 
circumvent mucociliary clearance on the individual particle level and to manufacture 
particles capable of a fast penetration through an unaltered mucus layer. 
Not only for the reasons mentioned above but also for toxicological considerations it is 
absolutely crucial to first understand the interactions of particles with such non-cellular 
barriers of the lungs. Here, several still open questions remain and are tackled in the 
presented work:  
• The study presented here aimed to give insight into the yet unknown dependence of 
the mucociliary clearance of particulate material on various particle properties such 
as size, shape, charge or surface properties to understand the mucociliary clearance 
on the microscopic level.  
• Furthermore, the investigation of the process of particle sedimentation and 
impaction upon deposition onto the mucus blanket was expected to explain what 
happens between the events of particle deposition and mucociliary clearance of the 
particle.  
• However, once deposited and while being transported via mucociliary clearance, it 
is still not clear if and by which mechanism (nano)particles may translocate through 
the mucus blanket, how this affects biodistribution of inhaled material and how this 
can be controlled by smart particle design. This is particularly important in terms of 
the connection between mucus’ microstructure, diffusion and overall particle 
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retention in the lungs. Therefore, the mobility of particles once trapped inside the 
mucus blanket and their interactions with the mucus mesh were assessed. Here, not 
only (adhesive) interactions between particles and mucus components and 
diffusion, but also the response of nanoparticles suspended in mucus and model 
gels to external force fields and the implications on mucus structure on the 
microscopic level were investigated as they were hypothesized to play a crucial role 
for particle mobility. 
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4. Mucociliary Clearance of Nanoparticles 
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is independent of size, shape and charge-an ex vivo and in silico approach. J Control 
Release 159(1): 128-134 
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4.1 Abstract 
 
The fate of inhaled particles after deposition onto the pulmonary mucosa is far from being 
solved, in particular with respect to mucociliary clearance and mucus penetration. Due to 
the fact that these phenomena govern pulmonary residence time and thus bioavailability, 
they are highly relevant for any kind of controlled release formulation delivered via that 
route. The work presented in the following section applied ex vivo approaches to 
investigate the dependency of muciliary clearance of micro-, submicron and nanoparticles 
on size, shape, charge and surface chemistry of such particles. In addition, measurement of 
mucociliary clearance of different particles also provided information about their 
penetration into mucus. Surprisingly, no significant differences in mucociliary clearance 
could be found for any type of particle under investigation. We hypothesized that particle 
penetration into the mucus gel layer is negligible at least within the time frame allowed by 
horizontal mucus transport. The presented data suggests that the observed lack of 
difference in mucociliary clearance is caused by the lack of immediate penetration of 
deposited aerosol particles into the mucus blanket.  
 
 
4.2 Introduction 
 
Before reaching the epithelial barrier, particulate drug carriers deposited onto mucosal 
tissues have to cross the mucus gel layer (Khanvilkar, Donovan et al., 2001; Cone, 2009; 
Sanders, Rudolph et al., 2009). In the context of local pulmonary drug delivery in the 
upper lungs, rapid mucociliary clearance of trapped drug carriers will put a serious 
limitation to any attempt of designing inhalable controlled release systems. Strategies to 
control the mucociliary clearance of pulmonary drug carriers without jeopardizing the 
important barrier function of pulmonary mucus e.g. by innovative particle design, therefore 
need to be addressed first, both scientifically and technologically.  
Mucociliary clearance dramatically influences the fate of deposited drug carriers: Inhaled 
particulate material is trapped and moved along with the moving mucus to be excreted by 
transport to the larynx (Iravani and Melville, 1976; Fulford and Blake, 1986; Antunes and 
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Cohen, 2007). Those processes have long been under investigation (Geiser, Cruz-Orive et 
al., 1990; Geiser, Serra et al., 1995; Geiser, Im Hof et al., 1997; Geiser, Gerber et al., 
2000), but are still not fully understood. In previous studies, the focus has mainly been laid 
on the macroscopic investigation of processes and parameters which influence the 
regulation of mucus secretion (Boucher, 2007) and clearance (King, 2006). Here, 
characterization of mucociliary clearance in healthy and diseased state (Donaldson, 
Corcoran et al., 2007; Livraghi and Randell, 2007) and under pharmacologically relevant 
conditions (Bennett, 2002) plays a large role in current research.  
Translocation of particles through pulmonary mucus has not been satisfactorily clarified so 
far, especially considering the fact that the pulmonary mucus blanket is continuously 
moving due to mucociliary clearance. This is particularly true for nanosized particles 
which are much smaller in diameter than the thickness of the mucus blanket.  
Considering the interaction of particles with a moving gel layer, it is not clarified yet, how 
such a translocation can be correlated with dynamic processes of the ciliary propulsion of 
this moving layer (e.g. fluid dynamics) as well as particle properties such as size, shape, 
charge and surface chemistry. Therefore, the aim of this study was to investigate and 
possibly identify critical particle properties which may influence their mucociliary 
clearance and translocation within the mucus blanket. Measuring the mucociliary clearance 
velocity of particles may also give insight into their penetration behavior into mucus: 
Whereas non-penetrating particles will be cleared with the moving mucus (figure 7A), 
particles that cross the mucus layer or even make contact with the epithelium (figure 7B) 
will on average be slowed down as they reach layers of smaller flow velocity (PCL and 
vicinity of the epithelium). Thus, they will show no, or at least a decreased average 
clearance velocity, which can be measured by particle tracking.  
The influence of particle properties, such as surface chemistry, size, charge and shape on 
mucociliary clearance (and indirectly on penetration potential) can be determined 
experimentally by the recently described ex vivo Embryonic Chicken Trachea (ECT) 
model (Henning, Schneider et al., 2008; Henning, Schneider et al., 2010) where horizontal 
particle trajectories can be imaged and analyzed. To improve comparison of clearance 
velocities of different particles and to reduce the statistical individual variance, we 
successfully applied a method to track particles of different type simultaneously.  
 
MUCOCILIARY CLEARANCE OF NANOPARTICLES 
 
- 20 - 
 
 
 
 
Figure 7: Non-penetrating particles (A) will be cleared with the moving mucus blanket. Penetrating particles 
(B) will, on average, be transported slower or even not at all by translocating to areas with negligible 
horizontal mucus velocity such as the vicinity of the epithelium. 
 
 
4.3 Experimental 
 
4.3.1 Materials 
Experiments were conducted with three main groups of particles: Size dependency was 
investigated with differently sized polystyrene (PS) particles, shape and charge 
dependency was analyzed with differently charged (COOH surface or polyethylenimin 
(PEI) coating, respectively) rod-shaped (aspect ratio ≈ 4) and spherical PS particles. 
Dependency on surface chemistry was investigated with maghemite particles of different 
surface chemistry.  
Spherical PS-COOH particles (nominal density ρp = 1050 kg/m³) were purchased from 
BangsLabs (Fishers, USA), rod-shaped particles were made by stretching spherical PS-
COOH particles purchased from Polysciences (Warrington, USA) according to the film 
stretching procedure previously described (Champion, Katare et al., 2007). PEI was coated 
on particle surface through passive adsorption: Particle suspension (108 particles/ml) was 
incubated 1:1 in 2 mg/ml PEI solution overnight with end-to-end mixing. Particles were 
washed two times in phosphate buffered saline (PBS, 5 mM) and stored at 4 °C. Washing 
was performed by 15 min centrifugation at 7000 rpm and subsequent resuspension. 
Maghemite particles were obtained from Chemicell (Berlin, Germany), had a mean density 
of ρp = 1250 kg/m³ and were assembled from 20 nm subunits. All particles, except for rod-
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shaped and PEI coated particles were purchased from commercial sources. Fluorescent 
label was fluorescein isothiocyanate (FITC) or 4',6-diamidino-2-phenylindole (DAPI) for 
reference particles, respectively, incorporated in the polymer matrix of the PS particles by 
the manufacturer.  
Maghemite particles, were coated with a lipophilic dye by the manufacturer. Subsequently, 
a second layer enveloping the particle with a hydrophilic polymer was attached by the 
manufacturer to protect the particles against aggregation by foreign ions (Tseng, Di Carlo 
et al., 2009; Cinti, Taranta et al., 2011). All chemical modifications were linked covalently 
to the surface of maghemite particles by the manufacturer (chitosan, starch, 
phosphatidylcholine (PC), polyacrylamide (PAA)). PS-COOH particles of 555 nm 
hydrodynamic diameter were applied as reference particles in all experiments. All 
chemicals used were of analytical grade and purchased from standard commercial sources. 
Fertilized eggs, specified as pathogen free, were obtained from Lohmann (Cuxhafen, 
Germany).  
 
 
4.3.2 Particle Tracking Experiments 
In the ECT model, particles were deposited onto excised trachea from chicken embryos. 
Particle movement was monitored by optical means. In this study, fertilized eggs were 
incubated for 18-19 days at 37 °C and 60 % humidity in a breeding chamber. Trachea were 
excised and particles deposited as described earlier (Henning, Schneider et al., 2008). 
Briefly, after isolation, trachea were cut into half pipes and aqueous particle suspension 
was deposited on their inner (mucosal) side by using a MicrosprayerTM (PennCentury Inc., 
Wyndmoor, USA) as displayed in figure 8. Particles were applied as a mixture of two 
different types of particles suspended in millipore water; in each case PS-COOH particles 
of 555 nm hydrodynamic diameter were used as a reference particle. The applied amount 
of particle suspension was approximately 0.1 µl (0.04-0.06 % solid fraction) per trachea.  
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Figure 8: Trachea were cut in half pipes and particles are deposited on top. Trapped particles (green) are 
transported horizontally by mucociliary clearance and can be tracked by fluorescent labeling. 
 
 
With an assumed joint thickness of 20 µm for PCL and mucus layer, the amount of liquid 
on top of the tracheal epithelium is 1.6 µl (taking into account average length and diameter 
of embryonic chicken trachea). The application of the particle suspension therefore 
represents the addition of 6.25 % fluid. According to previous studies (Powell, Aharonson 
et al., 1974) this was assumed not to influence the rheological properties of mucus 
significantly. Throughout the experiment, the half pipes were placed onto Locke-Ringer 
solution soaked tissue. After particle deposition, the half pipes were transferred into a 
humidity (99 %) and temperature (33 °C) controllable chamber. Particle transport velocity 
due to mucociliary clearance was measured by fluorescence microscopy (Axioimager, 
Zeiss, Jena, Germany). Clearance rates measured by this method are comparable to human 
clearance rates (Henning, Schneider et al., 2008) which range between 3-25 mm/min 
(Hofmann and Asgharian, 2003; Antunes and Cohen, 2007) All particles were fluorescent-
labeled to allow tracking of their transport in the x-y plane. Reference particles and 
particles under investigation were labeled with a different fluorophore and could therefore 
be distinguished. Particle trajectories were recorded as image sequences of 10 s length. 
Due to the fact that most particles left the frame after this time, longer sequences could not 
be imaged. Several sequences were recorded on different spots on each trachea and particle 
trajectories were analyzed. On average, 10-20 particle trajectories per sequence were 
analyzed. To investigate the dependency of transport velocity on particle shape, spherical 
and rod shaped PS particles were applied and tracked simultaneously. To investigate 
charge dependency of transport velocity, reference particles were applied and tracked 
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simultaneously with positively or negatively charged rod shaped and spherical particles, 
respectively. To complete these studies, the dependency of transport velocity on particle 
surface chemistry was investigated with maghemite particles coated with chitosan, PC, 
PAA and starch. In each case, the particle type under investigation was applied and tracked 
simultaneously with reference particles or compared directly (e.g. in the case of shape 
dependency). The mean transport velocity of each type of particle was calculated by 
MtrackJ software. The mean transport velocity of the reference particles in each sequence 
was set to 100 %. For each sequence, the mean transport velocity of reference particles was 
compared to the mean velocity of the particle type under investigation. 
 
 
4.3.3 Particle Characterization 
Particles were characterized by dynamic light scattering (DLS), scanning electron 
microscopy (SEM) and atomic force microscopy (AFM). DLS measurements were 
conducted with particle suspensions in millipore water with a Zetasizer Nano-ZS (Malvern 
Instruments, Herrenberg, Germany): Here, particle solutions provided by the manufacturer 
were diluted with millipore water to yield concentrations of approximately 108 particles per 
ml. SEM measurements were conducted with a JSM 7001F Field Emission SEM (Jeol, 
Tokyo, Japan) under high vacuum conditions and room temperature. Prior to scanning by 
SEM, particles were sputter-coated with gold (layer thickness approximately 10 nm). 
Accelerating voltage was 20 kV with a focal distance of 10 mm. Samples for microscopic 
imaging were prepared by coating freshly cleaved mica with aqueous particle suspensions 
(1:100 dilution of stock solution provided by the manufacturer) followed by gentle drying 
with compressed air. AFM scans were done using a Multimode V (Veeco, Plainview, 
USA). Particles were scanned using non-contact mode and scan rates of 0.7 Hz. Standard 
non-contact mode cantilevers were used to image dried particles on mica (OMCL-
AC160TS, Olympus, Essex, Great Britain). 
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4.4 Results 
 
4.4.1 Particle Characterization 
Characterization of the particles by DLS showed that all particles were monodisperse 
(table 1) with the criterion for sufficient monodispersity being a polydispersity index (PDI) 
below 0.2. Measurement of zetapotential could confirm the charge given by the 
manufactures as either clearly positive, negative or neutral. Visualization by microscopic 
means was used to examine morphology of the particles and to estimate values of size and 
dispersity as measured by DLS. Rod shaped particles could not be measured by DLS 
because this technique incorporates spherical particles as boundary condition and thus 
gives misleading results for nonspherical particles. Figure 9 displays AFM and SEM 
images of PS spheres, PS rods and maghemite particles. SEM and AFM data were in 
accordance with values measured by DLS. Maghemite particles show greater 
polydispersity as proposed by DLS data. Disintegration of maghemite particles (which had 
been assembled from smaller subunits) due to dehydration effects during sample 
preparation can apparently not be avoided completely. The assembly of the maghemite 
particles from smaller subunits (“multi domain magnetic core” as specified by the 
manufacturer) can be seen by the cluster-like appearance of the particles. PS particles seem 
much smoother and display very low polydispersity. 
 
 
 
Table 1: Particle characterization by DLS. All particle types show sufficient monodispersity (* indicates 
measurement in millipore water). 
 
 Particle surface 
chemistry 
Size 
 
[nm] 
Zeta potential 
* 
[mV] 
PDI 
[a.u.] 
maghemite 
particles 
chitosan 146.0 ± 0.5 40.1 ± 0.9 0.1 ± 0.01 
PC 160.6 ± 0.6 -39.9 ± 1.9 0.07 ± 0.01 
starch 176.5 ± 1.2 -0.9 ± 0.1 0.09 ± 0.02 
PAA 197 ± 1.5 -32.7 ± 0.8 0.12 ± 0.02 
uncoated 
maghemite 
165 ± 0.7 38 ± 1.1 0.14 ± 0.03 
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PS 
(reference particle) 
555 ± 6.3 -49.5 ± 0.4 0.04 ± 0.07 
PS (“200 nm”) 248.3 ± 1.4 -44.9 ± 0.4 0.004 ± 0.002 
PS (“1000 nm”) 926 ± 115 -32.4 ± 0.8 0.17 ± 0.09 
PS (“6000 nm”) 6242 ± 469 -32.7 ± 0.7 0.09 ± 0.07 
PEI-terminated PS (positively charged 
spheres) 
600.5 ± 7.0 41 ± 2.0 0.14 ± 0.08 
COOH-terminated PS (negatively 
charged spheres) 
555 ± 7.0 -42 ± 2.1 0.06 ± 0.03 
 
 
 
 
 
Figure 9: SEM (A-C) images as well as AFM images (D-F) of spherical and rod shaped PS particles (A, B, 
D, E) and maghemite particles (C, F). Maghemite particles show rougher surface and more heterogeneous 
shape than PS particles. Scale bar represents 1 μm for PS particles or 100 nm for maghemite particles. 
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4.4.2 Particle Tracking Experiments 
The ECT model was employed to visualize and analyze the transport of deposited particles 
by mucociliary clearance. Particle trajectories showed the effective and well directed 
clearance of trapped particles (figure 10). Particles were transported mainly 
homogeneously throughout the imaged sequences. Slight divergences in direction or 
velocity of transport by mucociliary clearance were probably caused by the convergence of 
different metachronal fields. Trachea with impaired ciliary activity could be distinguished 
by strongly heterogeneous, circular or even reverse particle transport.  
 
 
 
 
Figure 10: Trajectories of particles transported by mucociliary clearace. Slight differences in transport 
direction may be caused by the convergence of metachronal fields. Single trajectories (numbered) are shown 
in different color. Image size is 120 µm in width. 
 
 
The aim of this study was to investigate the influence of different parameters such as 
shape, size, charge and surface properties on the clearance behavior of micro- and 
nanoparticles after deposition. In this context, clearance transport velocity of different 
types of particles was analyzed. No significant difference in transport velocity between 
reference particles and particle type under investigation could be found for any data set, be 
it dependency on size, charge, shape or surface chemistry (One Way ANOVA-Sigma Plot, 
systat, Chicago, USA). To exclude a retarding influence of PS reference particles on mucus 
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clearance, chitosan coated and starch coated maghemite particles were compared by 
applying a different type of reference particle (maghemite uncoated). Again, the compared 
types of particles did not show a significant difference in mean transport velocity. Results 
regarding the possible dependency of clearance transport velocities of particles under 
investigation on particle size, charge, shape and surface chemistry are summarized in 
table 2. Comparably high error in table 2F is probably due to smaller sample size 
(ntrachea = 3). Although most particle ensembles were transported as uniform formation, 
demonstrating complete immobilization in the mucus blanket with little relative trajectories 
to each other, few particles in deeper layers could be observed. The magnitude of this 
effect was independent of particle characteristics and may indicate the existence of voids 
inside the mucus blanket.   
 
 
Table 2: Relative mucociliary clearance velocities of particles under investigation. Transport by mucociliary 
clearance is independent of particle size (A), shape (B), charge (rod shaped particles (C), spherical particles 
(D)) and surface chemistry (E). A retardation of all particles by PS reference particles may be excluded: The 
application of a different type of reference particle reproduces previously found velocity relations (F). Values 
are means ± CV, (trachea: n ≥ 4 (A-E), n = 3 (F); particles: n ≥ 100). 
Size dependency of clearance velocity (A)
Particle Relative difference of transport 
velocity to reference particle [%] 
Statistical error [CV] 
200 nm 2.7 10.7 
1000 nm 2.1 8.9 
6000 nm -6.0 8.8 
Shape dependency of clearance velocity (B)
Particle Relative difference of transport 
velocity to reference particle [%] 
Statistical error [CV] 
Rods 4.2 17.9 
Spheres 0 (reference)  
Charge dependency of clearance velocity (rod shaped particles) (C) 
Particle Relative difference of transport 
velocity to reference particle [%] 
Statistical error [CV] 
rods (+) 2.8 6.4 
rods (-) 7.6 11.5 
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Charge dependency of clearance velocity (spherical particles) (D) 
Particle Relative difference of transport 
velocity to reference particle [%] 
Statistical error [CV] 
spheres (+) 2.2 9.1 
spheres (-) 0.5 8.1 
Dependency of clearance velocity on surface chemistry (E) 
Particle Relative difference of transport 
velocity to reference particle [%] 
Statistical error [CV] 
PC -1.0 6.8 
chitosan 0.5 8.1 
starch 1.7 6.0 
PAA 10 14.0 
Dependency of clearance velocity on surface chemistry (influence of reference) (F) 
Particle Relative difference of transport 
velocity to reference particle [%] 
Statistical error [CV] 
chitosan 11.6 42.6 
starch 8.2 23.9 
 
 
 
4.5 Discussion 
 
The presented study describes the investigation of trajectories of individual particles upon 
impaction onto the mucus layer. This process is rather fast and horizontal transport by 
mucociliary clearance governs the order of magnitude of the relevant velocities. ECT 
experiments showed that relative clearance velocity of the particles under investigation did 
not differ from that of simultaneously measured reference particles. This simultaneous 
measurement allowed for a direct comparison of reference particles and particles under 
investigation. A dependency of shape, size, charge or particle coating on the relative 
transport velocity was not observed. Therefore, the clearance behavior and the transport 
velocity of particles deposited onto the mucus blanket seems to be mainly determined by 
the characteristics of the underlying mucus and its flow properties.  
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Experimental and theoretical studies (Matsui, Randell et al., 1998; Smith, Gaffney et al., 
2007; Smith, Gaffney et al., 2008) predicted heterogeneous flow velocities along the height 
of the mucus layer with smaller average velocities in the region of the PCL, the vicinity of 
the epithelium and finally vanishing flow at the epithelium. Therefore, penetrating particles 
will on average experience a decreased flow velocity and thus slower transport while 
advancing deeper towards the epithelium (figure 7). This is the reason for mucociliary 
clearance velocity of deposited particles being able to provide information about the 
penetration potential of such particles. Taking into account the presented results, the 
mentioned particle properties might thus not influence particle penetration.  
However, we have so far not considered the role of wetting and diffusion: It is well known 
from previous studies that wetting is a strong driving force to submerge particles in 
biological fluids (Gehr, Green et al., 1996; Gehr, Im Hof et al., 2000; Fiegel, Jin et al., 
2005). Although this behavior might not be influenced by shape, surface topography or 
surface free energy (Geiser and Kreyling, 2010) its influence on particle penetration can be 
important. It could previously be demonstrated that the existence of a surfactant lining 
strongly influences the immersion of particles into airway fluids (Schurch, Gehr et al., 
1990; Gehr, Green et al., 1996; Fiegel, Jin et al., 2005). The force caused by the interplay 
of particle wetting and surface tension of the surfactant layer can be strong enough to result 
in the displacement of the particle into the epithelium. From the physical point of view, it 
is important to stress that this particular effect only comes to pass (and has so far only been 
reported (Geiser and Kreyling, 2010)) if the particle size approaches the thickness of the 
fluid layer. In the scenario described here, smaller particles (especially submicron or 
nanosized particles) are deposited onto airway fluids. For those small particles, the 
described forces can maximally immerse the particle completely but cannot contribute to 
any further displacement within the mucus layer.  
Overall the presented results lead to the conclusion that the particle properties under 
investigation (size, shape, charge, surface chemistry) play only a minor role in their 
clearance behavior, i.e particles that are trapped in the mucus will be cleared at a velocity 
that is equal to the clearance velocity of the mucus, independent of particle properties. 
However, the mucus blanket does not appear totally uniform, either in surface coverage as 
well as in thickness (van As and Webster, 1972; Iravani and Melville, 1976; Sims and 
Horne, 1997). Therefore, besides fast penetration through the mucus blanket, the 
deposition on poorly covered patches of the epithelium (van As and Webster, 1972; 
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Moller, Felten et al., 2008; Geiser and Kreyling, 2010) followed by epithelial adhesion  
represents a further possibility to escape the mucociliary clearance. The latter 
phenomenon, although there has been extensive proof for such heterogeneity of the mucus 
blanket in thickness and coverage of the epithelium (Iravani and Melville, 1976; Im Hof, 
Gehr et al., 1997; Sims and Horne, 1997), is not easily accessed and has so far rarely been 
exploited for pharmaceutical purposes. Nanoparticles deposited on such patches of the 
epithelium which are only poorly covered with mucus, can slip through these voids inside 
the mucus blanket and reach the PCL or even the epithelium. The existence of a fraction of 
particles which may undergo this process was observed in this study and this may also be 
the reason for the discrepancy between fast horizontal transport of individual particles and  
previously reported long term (> 24 h) retention of fractions of inhaled nanomaterial 
(Moller, Felten et al., 2008) (with a clearance velocity of 2 mm/min particles deposited in 
the airways should be cleared from the lungs within maximally 2 h). Hence, for 
pharmaceutical applications, the more passive approach of enhancing the adhesion of 
particles to the epithelial cell surface as shown by Fischer et al. (Fischer, Aleman et al., 
2009) deserves high attention. The experimental results described here clearly suggest that 
in quantitative terms of particle retention in the airways, this mechanism of translocation 
may be at least equally important than direct particle penetration through mucus; an 
approach which combines these mechanisms is considered ideal. 
 In further studies, the role of mucus fluid dynamics and microstructure in the directed, 
vertical translocation of particles should be investigated: Here, not the local particle 
mobility and diffusion (Sanders, De Smedt et al., 2003; Lai, O'Hanlon et al., 2007; Lai, 
Wang et al., 2009; Sanders, Rudolph et al., 2009)  as usually described by quantifying the 
mean-squared displacement of particles (Valentine, Perlman et al., 2004; Lai, O'Hanlon et 
al., 2007; Crater and Carrier, 2010) should be measured; rather should it be cleared if voids 
inside the mucus blanket in its in vivo state are possibly interconnected and if and under 
which preconditions they allow particle translocation. Furthermore it should be clarified, 
how particle impaction and their trajectories influence sedimentation of deposited particles 
in mucus. Here, the underlying physical principles have been seldom considered in 
previous studies but need to be characterized first, before being able to describe particle-
mucus interactions satisfactorily. These points are further assessed in the following 
sections. 
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4.6 Conclusion 
 
In summary, clearance velocity of micro-, and nanoparticles, trapped in the pulmonary 
mucus blanket and transported by mucociliary clearance, was shown to be independent of 
size, shape, charge and surface properties of the particles under investigation. Direct 
comparison of transport velocities of simultaneously measured particle types allowed for 
an estimation of particle penetration through the mucus blanket, revealing that vertical 
penetration of particles into the mucus blanket may be negligible compared to their 
horizontal transport due to mucociliary clearance. Possible strategies to design particles 
capable to escape the otherwise very effective mucociliary clearance remain either a 
substantial increase in their diffusivity in mucus (mucopenetration), or minimizing 
mucoadhesion, targeting possible voids in the mucus blanket and seeking direct 
bioadhesion to the epithelial surface. Such a substantial increase in diffusivity or mobility 
of particles in mucus may be reached by the application of external forces to pull the 
particles through mucus. Before such approaches can be realized, however, the process of 
sedimentation in and impaction onto the mucus blanket of nanoparticles have to be 
clarified. Furthermore, mobility of particles inside the mucus mesh and the implications of 
mucus’ microstructure on such mobility have to be investigated. 
 
 
FLUID DYNAMICS OF PARTICLE-MUCUS INTERACTIONS 
 
- 32 - 
 
 
 
 
 
5. Fluid Dynamics of Particle-Mucus Interactions 
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5.1 Abstract 
 
Interactions of nanoparticles with respiratory fluids such as pulmonary mucus are currently 
under investigation and are involved in a variety of applications. The clearance processes 
especially for nanoparticles are still not fully understood. The study presented in the 
following section represents an approach to describe deposition, sedimentation and 
clearance of nanoparticles within mucus with numerical and analytical models. Here, the 
physical background of nanoparticle behavior in fluid flow was taken into account for the 
first time within this context. Particle impaction as well as sedimentation and mucociliary 
clearance were simulated with computational fluid dynamics (CFD) and described 
analytically. Furthermore mucus plasticity as pathway for complex particle translocation 
was simulated using advanced CFD methods. We could demonstrate that fluid dynamics 
strongly influence the fate of deposited nanoparticles in mucus: Sedimentation and 
impaction were shown to be unlikely to contribute to particle translocation. However, 
intrinsic plasticity of mucus slabs and collision of such slabs may enhance particle 
translocation towards the pulmonary epithelium. 
 
  
5.2 Introduction 
 
This study aims to describe interactions of nanoparticles with mucus as the major non-
cellular element of the mucosal barrier. Mucus is a complex fluid containing hydrogel-
forming glycoproteins (mucins) and forms a compact barrier in the upper lungs. It has a 
very active role in the protection from inhaled material: Material deposited in the lungs 
usually adheres to mucus and can therefore be transported cranially and finally be excreted. 
This process is called mucociliary clearance.  
Elimination of particulate matter by this mucociliary escalator reduces residence time and 
thus the amount of the drug at the site of action. Therefore, current approaches to increase 
bioavailability aim to enhance penetration of mucus by particles. On the other hand, one 
aims to increase the probability that particles remain at the deposition site (which seems 
only feasible if deposited on patches not covered with mucus). Which approach may be 
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favorable is not clear yet. Recent publications have described nanoparticle mobility in 
mucus depending on particle surface chemistry (Lai, Wang et al., 2009). However, those 
approaches solely rely on investigations concerning the MSD of particles already 
submersed in mucus but do not take into account any clearance processes or deposition 
effects. Although these processes have been under experimental investigation for quite 
long time (Geiser, Cruz-Orive et al., 1990; Geiser, Im Hof et al., 1997; Geiser, Gerber et 
al., 2000) they are still largely unexplored. The aim of this study was the description of 
particle deposition onto mucus with computational methods to clear if particles deposited 
onto the mucus blanket are able to cross the mucus layer and reach the underlying 
epithelium by impaction or sedimentation. In addition, the applicability of an analytical 
solution to the problem was investigated. The aim of such numerical and analytical 
approaches is the development of a model which allows for a quick estimation of particle-
mucus interactions in terms of particle trajectory inside the mucus blanket upon the 
deposition. This is necessary because it is seldom known how all physical interactions that 
are involved in particle displacement balance and thus determine the behavior of deposited 
particles of different properties. Furthermore, mucus plasticity was analyzed by CFD to 
assess additional possibilities of particle attachment or translocation to the epithelium 
(figure 11): It is known that the mucus blanket is heterogeneous not only in thickness but 
also in surface coverage, transport velocity and direction (Iravani and Melville, 1976). 
Therefore, mucus droplets of potentially even varying size may collide if being transported 
within different metachronal fields. Upon such collisions, particles deposited on the mucus 
blanket may be submerged and pushed deeper inside the mucus layer and may thus 
encounter the epithelium in the end. Another possibility of particles reaching the 
epithelium besides diffusion and impaction is the translocation due to mucus spreading: 
Mucus droplets, either directly upon secretion or after separation from larger entities, may 
spread if no confining barriers are located on the sides. This spreading was modeled to 
determine the magnitude of the time spans of such spreading phenomena and to find out if 
this behavior can indeed contribute to particle translocation to the epithelium. 
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Figure 11: Mucus plasticity due to spreading (top) and deformation upon collision of mucus slabs (bottom) 
may be the reason for particle translocation to the epithelium: Particles deposited on top of the mucus blanket 
will get into close contact of the epithelium during the spread of the mucus droplet. Collision may cause 
immersion of particle into the depth of the mucus layer. 
 
 
5.3 Experimental 
 
5.3.1 CFD and Analytical Solution of Particle Trajectories 
 
5.3.1.1 Computational Model 
To simulate particle deposition on top and sedimentation within the mucus layer a 2D 
model was applied. The plane chosen was orthogonal to the mucus and parallel to the 
mucus flow. The computation domain (figure 12) used was quadratic and had a side length 
of 100 µm. Numerical computation of the fluid flow and the particle dynamics was done by 
the commercial CFD tool Ansys Fluent 12.1 with an underlying regular rectangular 
numerical grid. For the upper and lower boundary, a no-flux boundary was set. On the 
upper boundary that represents non-moving air, the velocity is set to be zero. The lower 
boundary simulates propulsion of mucus by cilia by a moving wall approach. Here, a 
constant velocity was assumed as first approximation. All other boundaries were periodic. 
The hereby simulated flow was a multiphase flow, where air, mucus and particles are 
different phases. The interface between the air and the mucus phase is a so-called free 
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boundary, i.e. no shape can be prescribed. The shape of the interface is the result of several 
balanced forces. We could expect that the interface is a straight line since there is no force 
which might destroy this line shape. Hence, the surface tension could be neglected in this 
section. The simulations were done using the volume-of-fluid (VOF) model (Hirt and 
Nichols, 1981) to take into account the free boundary. The simulation of the particles’ 
paths was done by a Lagrangian method using Fluent’s discrete phase model (DPM). For 
the numerical as well as the analytical model viscosity of the mucus layer increased 
according to physiological values from 1 mPas at the bottom to 6 Pas (Lai, Wang et al., 
2009) at the mucus/air interface to represent gradual transition of the watery PCL to highly 
viscous mucus layer (Randell and Boucher, 2006). Determination of mucus flow velocity 
u(z) was achieved by simulating mucus flow as steady-state process. Particle motion inside 
mucus after impaction onto this fluid layer, however, is a non-steady-state process with 
adapted time step control. Maximum resolution in time was 2.2 x 10-9 s. Convergence was 
surveyed by monitoring the decrease of residuals. Here, a decrease of residuals to a plateau 
value of 10-6 was accepted as convergence criterion for all simulation results. 
 
 
 
 
Figure 12: Computation domain of particle mucus interactions displaying both phases (mucus and air). 
Boundaries are periodic and the grid consisted of 100 vertical and 320 horizontal cells.  
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5.3.1.2 Analytical Model 
In order to find the basic equation describing mucus flow only the important forces and 
effects had to be considered. By neglecting all terms not relevant for the described 
situation, the Navier-Stokes equation could be solved analytically. Due to the fact that 
propulsion of the mucus layer is uniform and continuous, the flow can be considered to be 
stationary. Additionally, as velocity and pressure are low the fluid can be considered to be 
an incompressible fluid. Further simplification could be made considering the Reynolds 
number. With the height of the mucus layer as the characteristic length a very small 
Reynolds number was obtained, as the height is small and the viscosity is rather high i.e. 
inertial forces are very small compared to the viscous forces. Therefore a laminar flow 
without turbulence could be assumed and the flow could be described by the stationary 
Navier-Stokes equation: 
 
       (4) 
 
Here, p represents the pressure, v = (u, k, w)T the velocity, µ the viscosity and f additional 
volume forces. In non-newtonian fluids the viscosity is usually dependent on ∂u/∂z. Here 
we could approximate by using µ = µ(z) which yields the same results if ∂u/∂z is linear. In 
the following, direction parallel to the mucus is denoted with x and the direction 
orthogonal to the mucus with z. The y-direction was not considered as the computation 
domain was chosen parallel to the flow direction. First, it could be assumed that the 
boundary conditions and the fluid properties in the x-direction are uniform and do not 
change in time. Furthermore, the pressure gradient in this direction is zero. That means all 
quantities do not depend on the position on x-direction. All these assumptions allowed for 
writing the equation for the velocity in x-direction u in the following form: 
 
         (5) 
 
Further simplification was included with respect to diffusion or Brownian motion of 
particulate matter: For spherical particles, the time t(b,b0) required to reach the cilia by 
Brownian motion is 
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         (6) 
 
with b = thickness of mucus, b0 = starting height of the particle trajectory. D is given by 
equation (2). Mucus viscosities range between 102 and 10-2 Pas (Lai, Wang et al., 2009). 
Therefore we could determine a diffusion coefficient for a viscosity of 50 Pas which lead 
(with an assumed thickness of 10 µm for the mucus blanket) to a value of 
t(10 µm) = 1.1 x 106 s (= 12.9 days). Even for highly diffusive particles (Lai, O'Hanlon et 
al., 2007) with t(10 mm) = 500 s, mucociliary transport velocity (typical value in ex vivo 
experiments: 2 mm/min) exceeds diffusional transport by far. Therefore it is plausible to 
neglect diffusional transport through the mucus blanket in a simple analytical model. 
Applied variables and parameters are summarized in table 3. 
 
 
Table 3: Applied variables and their denotations 
Variable Denotation 
 
p pressure 
µ viscosity 
v flow velocity 
u, k, w flow velocity in x, y, z direction 
V particle velocity 
U, K, W particle velocity in x, y, z direction 
uM, uA flow velocity in mucus or air respectively 
u0 drive velocity of the mucus layer 
r particle radius 
 
 
5.3.2 Simulation of Mucus Plasticity 
Numerical simulations of mucus plasticity and mucus slab deformation were done using 
the software tool Finite-Pointset Method (FPM) recently developed at the Fraunhofer-
Institute for Industrial Mathematics in Kaiserslautern, Germany (Tiwari and Kuhnert, 
2002; Tiwari, Hietel et al., 2006). FPM solves fluid dynamic problems and its numerics are 
based on a grid-free method, i.e. unlike other CFD tools like Fluent, FPM needs no mesh to 
FLUID DYNAMICS OF PARTICLE-MUCUS INTERACTIONS 
 
- 39 - 
 
discretize fluid mechanics equations but utilizes virtual particles which are transported 
with the fluid flow and act similar to fluid elements (Tiwari and Kuhnert, 2002). One 
major advantage of the method is the treatment of free boundaries as surfaces of the 
described mucus. A 2D-model of a mucus slab with a width of 20 µm and a height of 10 
µm was considered here. The friction force between the mucus and its underground cannot 
be determined exactly, however the composition and nature of the underlying watery PCL 
is known. Although the fluid within the PCL is not very viscous, support by constantly 
beating cilia, secretion and absorption mechanisms and macromolecular structures enables 
it to be retained as distinct layer. Therefore, we placed the mucus slab on a 60 µm wide and 
5 µm high layer of the same material but higher viscosity. This was done to result in a non-
moving stable substrate with, however, similar interfacial properties to simulate underlying 
PCL. Mucus density was chosen to be 1000 kg/m3 with a viscosity of 6 Pas (Lai, Wang et 
al., 2009). The viscosity of the underlying substrate was chosen 10 times larger. The 
temperature influence was not regarded. The resolution can be expressed by mean distance 
of virtual particles which is 0.13 µm in this case. As a solver for non-stationary problems, 
convergence is surveyed in each time step. The intrinsic convergence level for the equation 
solver is implied by the developer and the magnitude of this parameter cannot be given 
here. 
 
 
5.4 Results 
 
5.4.1 Particle Trajectories 
 
5.4.1.1 Analytical Solution 
In order to find an analytical solution the domain was divided into the mucus domain (M) 
and the air domain (A). Mucus is located in the height 0 < z < ΔH, the air domain is located 
in the height ΔH < z < H, where H is chosen large compared to ΔH. The velocities are 
denoted by uM(z) and uA(z) for the flow velocity in mucus and in air, respectively. The 
general solution of the Stokes equation could be obtained by integrating the equation two 
times: 
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                                                                                                               (7a) 
 .                                                                                           (7b) 
 
For the velocities in mucus and air following equations could be obtained: 
 
       .                             (8) 
 
It can be assumed that the viscosity of air is almost constant so that the equations could be 
simplified to 
 
       .                                                    (9)  
          
It remained to determine the unknown constants C1, C2, C3, C4. The complete solution 
could be obtained by choosing boundary and interface conditions. Therefore, the drive 
velocity of cilia was chosen as u0. Finally, the following velocities could be obtained: 
 
                                                                 (10a) 
.                       (10b) 
 
These two equations describe flow velocity u(z) of the mucus layer and the air above. The 
analytical solution of the flow velocity of the mucus layer uM(z) is compared to its 
numerical solution in figure 13. These results qualitatively match experimental (Matsui, 
Randell et al., 1998) as well as numerical results of previous studies which apply much 
more complex models for the ciliary drive of the mucus layer (Smith, Gaffney et al., 2007; 
Smith, Gaffney et al., 2008). Similar to those studies, mucus flow velocity was found to be 
almost constant along the mucus’ height. The knowledge about flow velocities of mucus 
depending on z was used to describe particle trajectories after deposition. 
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Figure 13: Comparison between numerical and analytical solution of mucus flow velocity depending on the 
height above the surface (interface between PCL and mucus). 
 
 
5.4.1.2 Particle Velocity and Path Inside Mucus 
In the following section, the velocity and the path of a particle inside the mucus flow after 
deposition is described. Under the assumption of a laminar flow, the drag force for a 
spherical particle can be written according to the Stokes law: 
 
                                                                                                                 (11) 
 
with µM = viscosity of the mucus, r = particle radius and Vrel = relative velocity between 
particle and fluid flow. To consider the vertical movement of particles (in z-direction, 
orthogonal to mucus flow), we released a particle into the mucus with some initial velocity 
W0 in z-direction. The particle motion is essentially determined by the balance of inertia 
force and drag force. As there is no flow in z-direction now, the equation of motion was 
given by 
 
                 (12) 
 
where mP is the particle mass. Here, f represents constant forces like gravitation and 
buoyant forces. The solution of this (ordinary differential) equation was 
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                           (13) 
 
where ρP is the density of the particle. To estimate the behavior of the velocity V(t), 
relevant values, for instance, ρP = 1125 kg/m3, r = 100 x 10-9m were considered. Mucus 
viscosity µM(z) was modeled as linearly increasing from 1 mPas at the bottom to 6 Pas at 
the mucus/air interface. As particles do not move much in z-direction, this can be 
approximated by using the constant value of 6 Pas at the air interface. Buoyant forces and 
gravitation forces result in values in the order of the size 10-17 N, whereas friction force is 
about 10-11 N for a typical mucus velocity of 2 mm/min. Thus, buoyant forces and 
gravitation force could be neglected compared to the friction force. Looking on the particle 
velocity, after t = 1.9 x 10-12 s the initial velocity has decreased to approximately 1 % of its 
original value. In addition, horizontal velocity (x-direction, parallel mucus flow) could be 
considered. The equation of motion was given by 
 
                (14) 
 
where uf is the flow velocity of the mucus (depends on z). Approximating that the particle 
does not move much in vertical direction it could be assumed that the particle is located in 
a constant height, hence, the fluid flow velocity at particle position is constant (uf = u0 = 
mucus drive velocity) which is feasible by looking at the only slightly decreasing flow 
velocity (figure 13, section 5.4.1.1). Using the equivalent equation of motion for the 
horizontal direction, the following solution could be obtained: 
 
.                (15) 
 
That means, the size of acceleration of a particle is the same as the deceleration in vertical 
direction. Hence, the particle immediately accelerates to flow velocity. Now, the particle 
path could be computed. In our case (with f = 0) the following equations could be 
obtained: 
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                                                                                    (16a) 
                                                                                            (16b) 
.                  (16c) 
 
In summary, particles deposited at the mucus air interface (t = 0) immediately accelerate to 
mucus transport velocity and uniform motion. This behavior is displayed in figure 14. Fast, 
de facto immediate, acceleration of particles trapped inside the mucus blanket causes the 
particles to show linear horizontal transport without a visible lag time. Here, numerical and 
analytical solution are in very good agreement.  
 
 
 
Figure 14: Vertical and horizontal particle transport upon deposition onto the the mucus layer. Particles are 
accelerated to horizontal mucus velocity by entrapment in the moving mucus layer which causes immediate 
horizontal transport. (A). Vertical particle velocity is decelerated immediately upon deposition to cause only 
slight penetration into mucus (B). 
 
 
Regarding the vertical motion of deposited particles, inertia does not play a role in particle 
kinematics, as their vertical motion is decelerated close to zero even if particles impact 
with a velocity of 100 m/s perpendicular to the mucus blanket. This causes only slight 
penetration into mucus. Here analytical and numerical solution show some difference, as 
step size in the numerical solution leads to falsely increased penetration depth. 
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5.4.2 Simulation of Mucus Plasticity 
Considering the presented results of particle mobility upon deposition, it could be shown 
that sedimentation of such particles within the mucus layer might not be a very probable 
mechanism for particle translocation across this layer. The question of possible further 
ways to access the underlying epithelium remains. One of those possibilities might be the 
displacement of particles by plastic deformation of the mucus slab itself or deposition on 
poorly covered patches of the epithelium. Here, on the one hand, the aim was to investigate 
if such mucus slabs are likely to retain their shape (i.e. retention of existing gaps within the 
mucus layer would also be possible) within physiologically relevant time spans (minutes to 
hours, the time needed to clear particles from the lungs). On the other hand plasticity of 
mucus slabs was analyzed to investigate whether particles deposited on top could access 
the epithelium by deformation of mucus slabs involving mass transport from top to bottom. 
Therefore, numerical grid-free methods (FPM) were applied which could simulate the 
plasticity of 2D mucus slabs of a given cuboid shape upon removal of restraining 
boundaries at the sides of the slab. These simulations gave insight into the time frame of 
deformation of mucus slabs and the velocity and direction of deformation by gravitational 
forces and diffusion. It was shown that mucus slabs can be considered rather stable in 
terms of deformation within physiologically relevant time spans: Figure 15 shows mucus 
slab deformation within a time span of 800 s. Here, figure 15A and 15B display the initial 
situation (t = 0), figure 15C and 15D represent mucus deformation after 400 s. Figure 15E 
and 15F display mucus deformation after 800 s.  
Within this time, the cuboid mucus slab decreases in height by approximately 40 %. 
Similarly, the slab flattens out and increases in surface. It can be shown that the magnitude 
of deformation velocity of mucus is greatest in the area of the upper edges whereas mucus 
in the area of the center of the slab shows smallest flow velocities. Concerning the 
magnitude of the horizontal mucus deformation velocity (ux, figure 15B, 15D, 15F), it 
could be shown that, again, areas of greatest velocity are located on the upper edges of the 
cuboid mucus slab. In summary, it can be concluded that the shape of such mucus slabs 
will be maintained within time spans of physiological relevance, where areas of greatest 
deformation and flow velocity are located on the upper edges of the mucus slab. 
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Figure 15: Deformation of cuboid mucus slab by gravitational forces and diffusion after 0 s (A+B), 400 s 
(C+ D) and 800 s (E+F). Images on the left (A, C, E) show magnitude of horizontal deformation velocity 
whereas images on the right (B, D, F) represent magnitude of total deformation velocity. Dimension of all 
data is m/s.  
 
 
5.5 Discussion 
 
5.5.1 Particle Trajectories 
The aim of this study was to describe the mobility of nanoparticles in a complex biological 
fluid such as respiratory mucus and the interactions of such particles with this fluid. 
Particle trajectories and mobility of inhaled particles during impaction and sedimentation 
within mucus and mucociliary clearance were solved numerically and analytically. In 
addition, mucus plasticity was numerically solved to investigate further possibilities for 
particle translocation across the mucus layer. Analytical and numerical considerations of 
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particles trajectories deposited onto mucus showed that inertia does not play a significant 
role in the movement of particles within mucus. It could be shown analytically as well as 
by simulation that particles which are deposited at the air-mucus interface immediately 
accelerate to the velocity of the moving mucus layer. Vertical motion of particles during 
deposition could also be solved numerically and analytically: Immediately upon 
deposition, vertical particle velocity is decelerated quickly close to zero i.e. particles do not 
penetrate significantly inside the mucus layer. Here, impaction velocity only plays a 
marginal role in the quantitative behavior of particle sedimentation. Although simulations 
were in good accordance with the analytical solution, slight differences were visible. These 
were most probably due to step size during simulation. However, all these findings are in 
accordance with previous experimental studies and simulations concerning mucus flow, 
even for models involving much more complex mathematical description of mucus 
propulsion by ciliated cells (Barton and Raynor, 1967; Fulford and Blake, 1986; Smith, 
Gaffney et al., 2007; Smith, Gaffney et al., 2008). 
 
 
5.5.2 Mucus Plasticity 
To assess further possibilities for nanoparticles to reach the underlying epithelium, 
plasticity of mucus structures was studied: It could be shown that deformation of mucus 
slabs might be slow enough to allow retention of mucus structures within physiologically 
relevant time spans, i.e. before the structures are cleared by ciliary propulsion (minutes to 
hours). This finding is supported by previous experimental work which showed that the 
mucus layer is heterogeneous in height, appearance and surface coverage over the whole 
airways and does not form one continuous layer (Iravani and Melville, 1976; Im Hof, Gehr 
et al., 1997; Sims and Horne, 1997; Gehr, Im Hof et al., 2000). From this, one could 
conclude that possible gaps within the mucus layer might be retained in shape such that 
particles deposited there would have direct access to the underlying epithelium. 
Furthermore, it could be shown that during deformation the upper edges of the mucus slabs 
are deformed with greatest velocity. Particles deposited there might be transported towards 
the epithelium within the mucus. Clearly the presented approach represents only a rough 
approximation to the real situation, as interfacial physico-chemistry was not included in the 
model. Surface tension and other related effects cannot easily be modeled and need to be 
thoroughly assessed to completely mimic mucus spreading. In addition to that, further 
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studies concerning exact particle position in this situation and collision of two or more 
mucus slabs and its influence on deposited particles should follow. In summary, the 
question of particle translocation across the mucus layer can be addressed in the following 
way: The presented findings show that particles deposited on top of the mucus layer are 
very unlikely to cross this layer by sedimentation, diffusion or impaction, at least within 
time spans of physiological relevance, i.e. before particles entrapped by mucus are 
excreted by mucociliary clearance. However, deposition of particles in gaps within the 
mucus layer which were shown in our studies to retain their shape at least for short- and 
mid-term considerations, may be a possibility for particles to directly access the 
epithelium. Furthermore, deformation or collision mucus slabs may also lead to 
translocation of entrapped particles to the epithelium due to mass transport on the edges of 
the mucus slabs.  
 
 
5.6 Conclusion 
 
In this section the role of mucus fluid dynamics in the process of mucociliary clearance for 
the fate of deposited particles was investigated. Both numerical and analytical solutions to 
the problem were applied. Although using several approximations, it could be shown that 
the presented results were in accordance to previous studies with much more complex 
models. Both solutions were also in sufficient accordance to each other. In principle, the 
presented study displayed the kinematic behavior of deposited particles. One main 
conclusion from the presented results is the fact that particles cannot penetrate the mucus 
blanket by impaction or sedimentation alone and seem to be rather immobile once 
deposited onto the mucus blanket. This is a fact which is in accordance to the results 
described in the previous section: Here no difference in mucociliary clearance of several 
parameters was found. This is particularly feasible as there is no relative velocity between 
the particles and the moving mucus layer as suggested by the results presented here. 
However, particle mobility and diffusion on the microscale have to be considered to 
complete the understanding of particle fate within the mucus layer of the lungs. This is 
approached in the section to come. 
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6. The Role of Micro- and Macrostructure of Mucus in 
Particle Mobility  
 
Parts of this chapter were published in: 
 
Kirch, J., Schneider, A., et al. (2012). Optical tweezers reveal relationship between 
microrheology and particle penetration of pulmonary mucus. submitted for publication 
 
 
 
 
The first author contributed the following points to the publication: 
• design, performance and interpretation of experiments 
• writing of the manuscript 
The second author of the publication performed experiments involving optical tweezers. 
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6.1 Abstract 
 
In this study the mobility of nanoparticles in mucus and similar hydrogels as model 
systems was assessed to elucidate the so far missing linkage between microscopic diffusion 
behavior and macroscopic penetration of such gels. Differences in particle adhesion to 
mucus components were strongly dependent on particle coating. Particles coated with 
2 kDa PEG exhibited a decreased adhesion to mucus components whereas chitosan 
strongly increased the adhesion. In spite of such mucoinert properties of PEG, magnetic 
nanoparticles of both coatings did not penetrate through native respiratory mucus, resisting 
high magnetic forces even for several hours. However, model hydrogels were, indeed, 
penetrated by both particles in dependency of particle coating, obeying the theory of 
particle mobility in an external force field. Comparison of penetration data with cryo 
scanning electron microscopy (cryo-SEM) images of mucus and the applied model systems 
suggested particularly high rigidity of the mucin scaffold and a broad pore size distribution 
in mucus as reason for the observed particle immobilization. Active probing of the rigidity 
of mucus and model gels with optical tweezers was used for the first time within this 
context to confirm such properties of mucus on the microscale, thus presenting the missing 
linkage between micro- and macroscopical observations: Due to high heterogeneity in the 
size of the voids and pores of mucus, on small scales, particle mobility will depend on 
adhesive or inert properties. However, particle translocation over distances larger than a 
few microns is restricted by highly rigid structures within the mucus mesh. 
 
 
6.2 Introduction 
 
Mucus is a complex fluid of spatially varying properties containing hydrogel-forming 
glycoproteins (mucins) that enable the exchange of nutrients, provide lubrication, and 
protect the body from environmental influences. A compact layer of this hydrogel covers 
the complete gastrointestinal tract, the urogenital tract and the epithelium of the upper and 
central lung. Especially in pharmaceutical research, the barrier function of mucus is of 
special importance. Translocation of particulate matter such as dust, pathogens like viruses, 
or pharmaceutical (nano)carriers through this barrier is currently under investigation but 
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still not completely understood. In contrast to pathogens or toxic agents, penetration of this 
mucus barrier is strongly desired for any kind of drug delivery device, such as 
(nano)particulate application systems. Here, especially modification of particles with 
polyethylenglycol (PEG) was reported to enhance particle diffusivity within the probed 
timeframe. On the contrary, chitosan is established as mucoadhesive, intending to increase 
bioavailability, but may thus decrease particle diffusivity.  
In the last years, the investigation of the microrheology of mucus in this context has been 
gaining momentum (Lai, Wang et al., 2009). In particular the discrimination between 
different filtering effects, their correlation with gel structure and further details on how 
such filtering is controlled are being investigated (Lieleg and Ribbeck, 2011). Furthermore, 
the influence of electrolytes such as bile salts on particle mobility in mucus is tackled 
(Macierzanka, Rigby et al., 2011). The most established parameters to describe filtering 
effects are pore size (Sanders, De Smedt et al., 2000) and particle-mucus interactions 
(Mura, Hillaireau et al., 2011). The pore size is derived either from imaging data or particle 
tracking experiments. Particle tracking also provides information on mucociliary clearance 
and particle interactions with components of the mucus' polymer mesh (adhesion to 
mucins). Current studies in this field either focus on pore size as limiting factor (Olmsted, 
Padgett et al., 2001; Dawson, Wirtz et al., 2003) or suggest the more complex interaction 
filtering of mucus rather than size-exclusion effects (Lieleg and Ribbeck, 2011). 
Concerning non-cryo microscopic imaging, a disadvantage of such methods is their 
susceptibility to artifacts due to their harsh conditions, staining, or sputtering. Particle 
tracking experiments on the other hand suffer from limitations either in short correlation 
time, small observed area, or both. An alternative to such small-scale mobility of particles 
in mucus are classical diffusion chamber studies which quantify translocated particle 
fractions (Sanders, De Smedt et al., 2000). Those studies, however, do not provide 
information about microscopic particle behavior and mucus structure. 
Therefore, although each being extensively investigated, the major problem in this field is 
the still missing linkage between penetration behavior on scales larger than a few 
micrometers and microrheology and -structure of mucus. The presented study bridges this 
gap through combination of advanced methods which, to our knowledge, have not been 
applied so far in this context. Initially, particle-mucus interactions were investigated by 
force spectroscopy to quantify adhesion of differently coated nanoparticles to mucus 
components to confirm mucoinert or mucoadhesive properties of the applied particles. 
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Penetration of such differently adhesive particles through mucus and model gels was 
investigated by quantifying penetration velocity of magnetic particles through capillaries 
filled with mucus or model gels. Penetration behavior was assessed considering the theory 
of particle mobility in a distinct force field. This macroscopic particle mobility was 
correlated to microscopic mucus rheology and structure. Here, cryo scanning electron 
microscopy (cryo-SEM) was applied which allowed for an unbiased determination of the 
native mucus structure. Furthermore, optical tweezers were used to passively and actively 
probe native respiratory mucus. This approach is unique in this context and demonstrated 
that one crucial point in particle mobility is not only the pore size distribution but also 
mucin scaffold rigidity which is not captured in regular methods to measure mucus 
microrheology. This combination of pore size and rigidity in mucus could be used to 
explain the mentioned discrepancy between micro- and macrorheology of mucus as well as 
between low long distance mucus penetration and previously observed microscopic 
particle mobility. 
 
 
6.3 Experimental 
 
6.3.1 Materials 
All particles were obtained from commercial sources: For force measurements, PS 
particles with covalently linked coating (chitosan and polyethylenglycol (PEG, 2 kDa), 
500 nm diameter, Kisker Biotech, Steinfurt, Germany) were used. Capillary penetration 
experiments were conducted with dextran iron oxide composite particles with covalently 
linked coating (chitosan and PEG, 2 kDa) with a diameter of 170-200 nm (Micromod, 
Rostock, Germany). For the experiments with the optical tweezers, either 
polymethylmethacrylate (PMMA) beads (Fluka Productions GmbH, Buchs, Switzerland) 
with a size of 4 µm or melamine resin beads (Fluka Productions GmbH, Buchs, 
Switzerland) with a size of 5 µm were used. For optical tweezer experiments, the 
observation of the samples was done with a Gene Frame (ABgene, Epsom, United 
Kingdom), a special sample cell with a low volume of 25 µl. All chemicals used were of 
analytical grade and purchased from standard commercial sources. Nanoparticles were 
characterized regarding their size distribution by nanoparticle tracking analysis (NTA). 
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Measurements were performed with a LM10-HS (NanoSight, Amesbury, United 
Kingdom). This technique was previously demonstrated to be more precise in determining 
particle size distributions than standard dynamic light scattering (DLS) especially for 
polydisperse samples (Filipe, Hawe et al., 2010). Particle size distribution is displayed 
below (figure 16).  
 
 
 
Figure 16: Particle size distribution (hydrodynamic diameter) of PS particles (A+C) and magnetic dextran 
particles (B+D) with PEG 2 kDa coating (right) or chitosan coating (left). Size distribution is averaged over 
n = 3 independent experiments. 
 
 
6.3.2 Atomic Force Microscopy 
AFM cantilevers were cleaned and modified according to a previously described procedure 
(Gfeller, Nugaeva et al., 2005). In short, cantilevers were cleaned twice in piranha etch 
(97 % H2SO4 in 30% H2O2; 1:1), rinsed in millipore water and dried under nitrogen flow. 
Cantilevers were suspended in silane solution (1 % 3-glycidyloxypropyl-trimethoxysilane, 
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0.5 % N-ethyldiisopropylamine in water-free toluene) for 4 h at room temperature to form 
a self-assembled monolayer (SAM), providing a hydroxyl-reactive surface towards 
primary hydroxyl groups of mucins. After silanization, cantilevers were rinsed twice for 
20 min with dry toluene and dried under nitrogen flow. Subsequently, cantilevers were 
suspended overnight in 1 % mucin solution followed by a rinsing with millipore water. The 
sample substrate was silica, cleaned equally as the used cantilevers. A drop of particle 
suspension (chitosan or 2 kDa PEG coated polystyrene particles respectively in millipore 
water) was placed onto the substrate and dried in air. These samples were used in 
subsequent force imaging. Samples were inserted into the fluid cell of the AFM 
(Multimode V, Bruker, Santa Barbara, USA). Measurements of force plots (force 
spectroscopy) were done via so-called force volume imaging in fluid conditions where a 
surface is scanned while recording force-distance plots for each pixel of the image 
(figure 17). Force volume images (4096 force plots per image) were taken of the samples 
with 10 nN trigger force and a surface dwell time of 1 s. Force plots attributed to the 
particles were extracted, analyzed and compared to the force plots attributed to the 
substrate with nanoscope 7.13 software (Bruker, Santa Barbara, USA). Adhesion force was 
averaged over all force plots attributed to one particle. Several particles (n > 6) were 
analyzed and the statistical variation in average adhesion force among the particles 
considered as statistical error. 
 
 
 
Figure 17: Force volume imaging allowed for the discrimination between mucoadhesive (red) and mucoinert 
particles (blue) by the magnitude of adhesion to the mucin functionalized cantilever tip (left). SEM images of 
the modified tip (right) display the dense layer of mucin on the tip. 
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6.3.3 Capillary Penetration Experiments 
Capillary penetration experiments were conducted according to a method recently 
introduced by Kuhn et al. (Kuhn, Hallahan et al., 2006). Briefly, capillaries were filled 
with a model gel or respiratory mucus, respectively and sealed with vacuum grease on one 
end. 10 µl of particle suspensions (chitosan or 2 kDa PEG coated magnetic dextran iron 
oxide composite particles, Micromod, Rostock, Germany) were pipetted on top of the gel 
column. Filled capillaries were placed upright with their sealed end in a reproducible 
position in 2 mm distance to the pole of a neodymium magnet (figure 18). Capillaries were 
fixed in a reproducible position next to the pole of the magnet (neodymium permanent 
magnet). 
 
 
Figure 18: Gel filled columns were placed upright next to the magnet. Nanoparticle suspensions were filled 
on top of the gel columns. Magnetic particles were pulled through the hydrogel mesh upon exposure to the 
magnetic field. 
 
 
A fit with the model of Chrambach and Rodbard was done according to a procedure 
described previously (Sarbolouki, Mahnam et al., 2004). Here particle mobility in an 
external force field as described as function of gel concentration is given by 
 
                  (17) 
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where m is the particle mobility, m0 the mobility in water, c the polymer concentration, and 
k the system specific constant. Velocity of the magnetic particles while being pulled 
through model gels or mucus was obtained by measuring the travelling time of the particle 
at a fixed position in 2-4 mm distance to the pole of the magnet.  
Native respiratory mucus was obtained during bronchoscopy of a healthy horse and stored 
at -80 °C. According to previous studies, storage should not influence mucus rheological 
properties (Gastaldi, Jardim et al., 2000). There was no access to mucus of further healthy 
individuals. Model gel was hydroxyl-ethyl-cellulose (HEC, SE Tylose GmbH & Co. KG, 
Wiesbaden, Germany) of various concentrations. To prepare model gels, the respective 
amount of HEC was dissolved under overnight stirring in millipore water. 
 
 
6.3.4 Cryo-SEM 
HEC hydrogels and native respiratory mucus were imaged by cryo-SEM. HEC gels were 
prepared by dissolving the respective amount of HEC in millipore water. Before SEM 
imaging, HEC gels and mucus were collected in a thin dialysis capillary. Gel-filled 
capillaries were immediately frozen in liquid propane, to only allow formation of 
amorphous- and circumvent formation of crystalline water. Capillaries were cut into 
smaller pieces to subsequently image the brim of the cut. Sublimation of frozen, 
amorphous water inside the porous HEC gel and mucus was carried out for 1 h at -100 °C 
(Baltec SCD 500 Sputter coater, Baltec/Leica, Germany). Subsequently, the surface of the 
dry polymer scaffold was sputter coated with platinum (layer thickness approximately 
12 nm. After sputtering, samples were transferred into the SEM (DSM 982 Gemini, Zeiss, 
Jena, Germany) and imaged at -120 °C and 5 keV with 5-6 mm working distance. 
 
 
6.3.5 Optical Tweezers 
To probe the microstructure of the respective medium, the choice of the bead had to be 
adapted to the optical properties of the fluid. In 1 % HEC gel (refractive index ≈ 1.33) 
PMMA beads (refractive index ≈ 1.48) were used while in mucus melamin resin beads 
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(refractive index ≈ 1.68) proved to be the optimal choice. Here, the difference in 
refractive index should be maximized. For the preparation of the samples, a small volume 
of beads (2-4 µl) with a solid content 10 % was mixed with about 100 µl of the respective 
fluid. The concentration of beads was chosen in a range of 200-2000 ppm, so that 
hydrodynamic interactions between multiple beads could be neglected. Following the 
mixing process, all samples were vortexed for about five minutes to make sure that the 
beads were distributed homogeneously within the fluid. 25 µl of this mixture were filled 
into the sample holder and sealed airtight with cover glasses and vacuum grease. 
The setup of the optical tweezers was identical with the one used by Ziehl et al. (Ziehl, 
Bammert et al., 2009). The beam of a solid state laser (Ciel, Laser Quantum, Cheshire, 
United Kingdom) was guided towards the oil immersion objective (numerical 
aperture = 1.4, 60 x magnification) to create a harmonical trapping potential within its 
focal region inside an inverted microscope (Eclipse TE2000-S, Nikon GmbH, Duesseldorf, 
Germany). The visualization of trapped beads was achieved by illuminating the sample 
with an LED illumination source (ZLED CLS 9000, Zett Optics, Braunschweig, Germany) 
from above in the inverse direction of the laser beam through the sample cell onto the chip 
of a high speed camera (HiSpec 2G, Fastec Imaging, San Diego, CA, USA). The beads 
were recorded for a duration of 16 s with a sample rate of 16 kHz and tracked afterwards 
by the means of a cross correlation algorithm realized in LabView 2011 (National 
Instruments Germany GmbH, Munich, Germany) which allowed for the determination of 
the particle displacements with a spatial resolution of approximately 2 nm (Cheezum, 
Walker et al., 2001).  
Two types of measurements were conducted: In passive tracking experiments, a bead was 
held in place by the trap and the Brownian motion was recorded as reported above. Active 
experiments were performed by moving the piezoelectric stage of the setup in a triangular 
oscillation pattern induced by the signal of a waveform generator. The amplitude and 
frequency of the oscillation were chosen according to the mobility of the bead at its current 
position (usually between 1 µm and 4 µm and respectively 0.1 Hz and 0.2 Hz). The 
observation time was chosen in a way that at least two full oscillation periods could be 
recorded. Synchronous to image acquisition the voltage signal driving the stage was 
recorded by a data acquisition card (National Instruments Germany GmbH, Munich, 
Germany). All optical tweezers measurements were performed at a temperature of 20 °C. 
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6.3.5.1 Determination of the Shear Moduli 
The shear moduli were determined from the displacement data of beads that were confined 
in the focal region of the optical trap. This was achieved for mucus as well as for the HEC 
model gel by a method proposed in 1997 by Schnurr et al. (Schnurr, Gittes et al., 1997) 
according to which the Fourier-transformed displacements (࢞෥) are linked to the force 
spectrum of Brownian motion (ࡲ෩) by a response function ࢻ෥, the compliance, which is a 
complex function of the frequency ω for non-Newtonian fluids. 
 
.                  (18) 
 
Here, Fourier-transformed quantities are denoted by a tilde and the compliance is given by  
 
                        (19) 
 
while the power spectral density (PSD, ൏ |ݔ෤ሺ߱ሻ|ଶ ൐) of the particle displacements can be 
related directly to the imaginary part of the response function α'' by applying the 
fluctuation-dissipation-theorem (Landau and Lifshitz, 1966). The parameter α' can be 
obtained by applying the Kramers-Kronig-relations as previously demonstrated (Addas, 
Schmidt et al., 2004): 
 
                                                                                        (20a) 
.                                 (20b) 
 
The connection between the compliance of the material and its shear modulus is finally 
given by 
 
                   (21) 
THE ROLE OF MICRO- AND MACROSTRUCUTRE OF MUCUS IN PARTICLE MOBILITY 
 
- 58 - 
 
where the shear modulus is given as  
 
.                (22) 
 
At this point knowledge of the strength k of the optical trap is required because it 
influences the elastic properties of the fluid over the whole frequency regime in form of an 
additive constant: 
 
.                  (23) 
 
In the case of the HEC model gel these were determined directly out of the passive 
measurements by using the equipartition of energy relating the thermal energy with the 
harmonic trapping potential (Simmons, Finer et al., 1996). Due to the strong confinement 
of the polymer network however this was not possible in mucus. Instead the calibration of 
the trap strength was performed within a second sample cell containing water. The typical 
strength of the optical trap used in the experiment ranged between 3 pN/µm and 8 pN/µm. 
The frequency at which the corresponding apparent elastic modulus was reached also 
defined the lower data cut-off, typically around 1 Hz. The shear modulus at even lower 
frequencies would only represent the characteristics of the trap instead of those of the 
fluids. As upper cut-off, a frequency of 3.5 kHz was chosen which lies well below the 
Nyquist frequency (Shannon, 1949) of in our case 8.192 kHz. This choice was motivated 
by the minimization of aliasing errors. 
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6.4 Results 
 
6.4.1 Force Spectroscopy 
Determination of adhesive interactions between mucin fibers and nanoparticles of different 
surface chemistry could be realized by force spectroscopy. Direct comparison of adhesion 
forces between nanoparticles and silica substrate allowed for an unbiased comparison 
between chitosan and PEG (2 kDa) coated PS-nanoparticles. Relative adhesion compared 
to the substrate as shown in figure 19 demonstrated that chitosan coated particles adhered 
much stronger to mucin fibers attached to the tip of the cantilever than PEG coated 
particles. Whereas adhesion force between mucin functionalized tip and chitosan coated 
particles was over 250 % stronger than to the substrate, PEG coating of nanoparticles even 
resulted in a reduced adhesion compared to the bare silica substrate. 
 
 
Figure 19: Adhesion of differently coated nanoparticles to mucin fibers compared to underlying silica 
substrate. Data shown as mean ± SD. 
 
 
6.4.2 Capillary Experiments 
Penetration of magnetic particles over macroscopic distances in mucus and model gels was 
investigated by the method of Kuhn et al. (Kuhn, Hallahan et al., 2006). This method 
allowed for the analysis of direct translocation and penetration behavior of differently 
coated magnetic nanoparticles over defined distances in mucus and model systems. 
Investigation of penetration behavior over such distances may predict the potential of 
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particles to translocate through thick physiological mucus barriers rather than other 
methods. 
To show the feasibility of the method and to perform a proof-of-principle, capillary 
experiments were conducted with HEC gels as a model system. Here, gradual transition 
from water to dense hydrogels was realized by applying HEC gels of gradually increasing 
concentration and thus also gradually increasing viscosity and elasticity. Penetration 
experiments were conducted with both types of particles (chitosan coating as well as 
PEGylated nanoparticles) which penetrated HEC gels allowing for the calculation of 
penetration velocities (figure 20). 
 
 
Figure 20: Penetration of PEGylated and chitosan coated magnetic nanoparticles through 1% HEC gel 
within 5 minutes (top). Penetration velocity wass inversely related to gel viscosity and thus polymer 
concentration which could be fitted with the Chrambach-Rodbard model (R2 PEG = 0.93). Adhesion of 
chitosan coated particles to cellulose fibers can be confirmed by drop in penetration velocity (bottom). Data 
shown as mean ± SD, n ≥ 3. 
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It was shown that penetration velocity was indeed strongly dependent on rheological 
properties and polymer concentration of the model gel (figure 20, bottom): Penetration 
velocities of the particles in the HEC gel of the highest concentration decreased to 
approximately a tenth of their initial value as measured in millipore water. Correlation of 
particle velocity with polymer concentration of the respective hydrogel can be used to 
assess the accordance of penetration behavior with theoretical models describing particle 
mobility in a force field. Fitting of penetration velocities with the model of Chrambach and 
Rodbard (Chrambach and Rodbard, 1971; Sarbolouki, Mahnam et al., 2004) shows that in 
general, sufficient congruence can be reached for the penetration behavior of PEG particles         
(R2 PEG = 0.93) which exhibits greater conformity with the mentioned model than 
penetration behavior of chitosan coated nanoparticles: Here a fit with sufficient goodness 
could not be achieved. Performing the same experiments with native respiratory mucus, it 
could be shown that mucus is indeed a “tenacious fluid” (Florey, 1962): No penetration 
into, let alone through the mucus column could be observed (figure 21). This was true even 
for very long exposure (> 3 h) to the magnetic field. A difference between chitosan coated 
or PEGylated nanoparticles in this behavior could at no point be observed. 
 
 
Figure 21: Magnetic PEG coated nanoparticles did not penetrate into a mucus filled column even within 
incubation times longer than 3 h. 
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6.4.3 Cryo-SEM 
Structural analysis of mucus and HEC gels was performed with cryo-SEM. The structure 
of the polymer matrix of mucus and the differently concentrated HEC gels could be 
imaged in their native state. The porous polymer scaffold of the gels could be visualized 
with high resolution (figure 22-25) Pore size could be determined to range between 
approximately 100 nm to 500 nm in HEC of 0.5 % concentration (figure 22). With 
increasing polymer concentration, HEC hydrogels exhibit decreasing pore sizes as the 
polymer mesh becomes more condensed (figure 23). The average thickness of the fibers of 
the polymer scaffold can be determined to approximately 20 nm. Cryo-SEM imaging of 
mucus gel revealed a very different structure of the mucin polymer mesh: In mucus, large 
pores are heterogeneously combined with very small pores. Pore sizes of mucus ranged 
between approximately 100 nm and voids of several micrometers in diameter (figure 24). 
Furthermore, the thickness of the fibers of the polymer scaffold could be determined to be 
much higher than in HEC gels (figure 25). 
 
 
 
Figure 22: HEC gels of low concentration exhibit a very airy mesh structure with thin polymer fibers and 
large, quite homogeneous pore sizes. 
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Figure 23: With increasing polymer concentration, the mesh of HEC hydrogel becomes more condensed and 
the sizes of the pores become smaller. 
 
 
 
 
Figure 24: Mucus exhibits a very heterogeneous structure with a very broad pore size distribution from voids 
of several micrometers to small pores below 100 nm. The area marked with a white square is displayed in 
figure 25. 
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Figure 25: Polymer fibers in mucus are much thicker than in HEC hydogels and form very thick pore walls, 
suggesting a high rigidity of the polymer mesh. Pores can be very small and do not seem to be very well 
connected. 
 
 
6.4.4 Optical Tweezers 
Optical tweezers as a non-invasive tool were applied to probe the microrheology and 
particularly the rigidity of the polymer scaffold on the micrometer scale. Here, native 
respiratory mucus as well as HEC model gels were analyzed in this regard with stationary 
and oscillating optical traps. In the case of the stationary, passive tracking experiment, a 
single bead was confined to a small spacial volume and the displacement from the center 
of the trap was recorded. Afterwards the MSD was calculated (figure 26 & 27). It is linked 
to the diffusion coefficient D of a fluid by the generalized Stokes-Einstein-equation 
(equation 3). In the case of a simple Newtonian fluid which does not show any elastic 
behavior, the coefficient α is equal to 1 and the MSD increases linearly with time. In 
contrast, for complex fluids like hydrogels the history of former deformations plays an 
important role on its flow properties and α may become bigger (superdiffusive behavior) or 
smaller than 1 (subdiffusive behavior). The one-dimensional MSD of the beads out of the 
center of the optical trap in dependency of the correlation time t of mucus (figure 26) and 
the HEC model gel (figure 27) is displayed below.  
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Figure 26: MSD values of the applied microparticles measured in native pulmonary mucus. Large range in 
the slope of the MSD values determines strongly heterogeneous, locally varying rheological properties. 
Symbols refer to different samples and different sites within the sample (nsamples ≥ 3). 
 
 
 
 
Figure 27: MSD values of the applied microparticles measured in HEC hydogel (1 %). MSD values do not 
depend on site as observable by the highly homogeneous slopes. Symbols refer to different samples and 
different sites within the sample (nsamples ≥ 3). 
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The data cut-off for long times was chosen at the point where the MSD reached a plateau 
defined by the constrictions either due to the optical trap or the polymer scaffold. 
Extensive heterogeneity of mucus morphology as suggested by cryo-SEM studies could be 
confirmed: Highly diverse slopes of the MSD of particles in mucus in dependence of 
correlation time indicate strongly varying local properties. Consequently, the observed 
range in absolute values suggests a large variety in particle mobilities that spans more than 
an order of magnitude at all observable correlation times. On the contrary, for HEC (1 %) 
the measured MSD values lay within a much smaller range, thus demonstrating a high 
rheological homogeneity of the bulk hydrogel. 
Calculating storage and loss moduli, it was found that the microrheology of mucus presents 
itself much more diverse than that of HEC. While the mean range of the storage modulus 
in mucus (figure 28A) covered a whole order of magnitude at each frequency over the 
whole frequency regime, the fluctuations in HEC (figure 28C) were a lot narrower and 
typically did not move further apart than a factor of 2. The only exception were the moduli 
at lower frequencies than 20 Hz which showed a significant scatter which may be due to 
thermal drift of the piezo stage. Similar information could be deducted from the loss 
moduli (figure 28B and 28D), where, again, the range in mucus is even more significant. 
In general the presented results imply a similar elastic as well as viscous behavior of 
mucus and HEC at frequencies between 10 Hz and 1000 Hz, differing mainly in terms of 
high material heterogeneity in mucus and high homogeneity in HEC gels respectively. 
In the HEC model gel, material homogeneity could be recovered not only from the 
uniformity of the MSDs at different locations within the gel but also when considering 
displacements at a certain spot in different directions i.e. along the x- and y-axis of the 
pictures taken by the high-speed camera (figure 29). As displayed in figure 29B both 
curves overlap almost completely. On the contrary, in mucus strong deviations in the 
behavior of the MSD could be seen when comparing the x- and the y-direction of the 
trajectories (figure 29A). When comparing the values of the MSD along the y-axis at  
0.35 ms and 1 s, there is only an increase by a factor of 3.25 while along the x-axis the 
values increase much steeper by a factor of 10.  
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Figure 28: Storage- and loss moduli of mucus and HEC gel. Similar to MSD data, mucus (A+B) exhibits 
broad ranges of loss- and storage moduli. Contrary, HEC hydrogel shows homogeneous distribution of both 
moduli (C+D). Symbols refer to different samples and different sites within the sample (nsamples ≥ 3). 
 
 
Figure 29: Material homogeneity is additionally displayed by comparing MSD data for x- and y-direction for 
mucus (A) and HEC gel (B). In mucus, both curves differ significantly demonstrating high material 
anisotropy whereas for HEC gels, both curves align well, demonstrating isotropic behavior. 
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Importantly, although suggesting quite similar microrheology for both systems (either the 
MSDs or the shear moduli), the clear difference in material homogeneity between mucus 
and HEC gel is in accordance with the completely different macroscopic penetration 
behavior of particles in mucus and HEC. Yet, according to the fluctuation data, both 
materials should react similarly at least on a microscopic scale. To grasp these seemingly 
contradictory properties, additional, active experiments had to be performed: Here, a bead 
was caught in the trap and the piezoelectric stage the probe cell rested on was moved in a 
triangular wave pattern. The motion of the stage and the displacements of the bead 
relatively to the center of the trap were recorded. It could be shown that trapped particles 
can easily be moved through the HEC gel (1 %) as the particle followed the moving trap 
(figure 30B), i.e. the force exerted on it by the laser was sufficient to distort, stretch, or 
even rupture the polymer scaffold of the dense HEC gel. On the contrary, active 
measurements within mucus (figure 30A) showed that most beads could not be moved 
significantly, demonstrating the high rigidity of the polymer scaffold.  
 
 
Figure 30: Active measurements by oscillating trapped beads reveals rigidity of the mucus mesh as trapped 
beads cannot be moved within the mesh while the trap is displaced by 1 µm in each direction (A). In HEC gel 
(B) the trapped bead follows the trap during the complete oscillation cycle. 
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6.5 Discussion 
 
6.5.1 Force Spectroscopy 
So far adhesive interactions between mucin fibers and differently coated nanoparticles 
were usually investigated via quantification of mucin adsorption to these particles. In such 
studies (Yoncheva, Lizarraga et al., 2005), PEGylation was shown to reduce mucin 
adsorption and thus adhesion. The presented results are in good agreement with those 
studies as increased adhesion with chitosan coating and decreased adhesion by PEGylation 
could be confirmed. However, the approach presented here has the advantage of comparing 
both types of particles directly with the underlying substrate as intrinsic control. Thus, the 
results presented here are independent on the used cantilever and its tip geometry which 
greatly influences adhesion data and has so far been an unsolved problem in the 
methodology of force spectroscopy. While PEGylation of particles to decrease adhesive  
interactions with mucus or mucins is a quite recent approach, application of chitosan 
coating to increase such interactions has been widely accepted (Smart, 2005). Thus, the 
influence of such different coatings on particle mobility in mucus of various sources has 
been accessed by different methods. However, as mentioned before, those methods suffer 
from several limitations. Therefore we applied a just recently developed method to probe 
long-distance/long-term particle mobility to increase to proximity to the in vivo situation. 
Here, particle mobility in mucus is investigated for time scales and spatial distances of 
higher physiological relevance as presented in section 6.4.2. 
 
 
6.5.2 Capillary Experiments 
The observed behavior was in accordance with theoretical description of the particle 
penetration through gels: The applied model describes penetration of spherical particles 
through hydrogels by application of an external force field (e.g. electrostatic or magnetic 
forces). The fact that this model incorporates inert i.e. non-adhesive particles as boundary 
condition may be the reason for the greater goodness of the fit for PEGylated particles: 
Similar to their interaction with mucins, chitosan coated particles may interact adhesively 
with HEC fibers. As HEC fibers are polysaccharides, chemical similarities to 
polysaccharide side chains of mucins over large areas cannot be doubted. Thus, HEC gels 
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might mimic mucus gel and its adhesion to chitosan or chitosan coated particles. This 
adhesive interaction is supposed to be largely due to electrostatic interactions (Andrews, 
Laverty et al., 2009).  
Furthermore, the model of Chrambach and Rodbard allowed for an estimation of the 
average pore size of the gel: According to this model, the pore size equals the size of the 
probe particles when penetration velocity drops to 50 % of its initial value. Considering the 
fit of penetration velocity of PEGylated particles, this means that the average pore size of 
HEC gels should be approximately 200 nm for concentrations around 0.5 % which could 
later be confirmed by cryo-SEM images of HEC hydrogels (section 6.4.3). 
The fact that both types of particle did show penetration through HEC gels but not through 
mucus indicated the need to further characterize both systems. Therefore, the structure of 
mucus and HEC gels was analyzed by cryo-SEM imaging of native respiratory mucus. 
 
 
6.5.3 Cryo-SEM 
The results presented here could confirm the findings obtained by the described capillary 
experiments: Indeed, a pore size approaching the diameter of the penetrating particles of 
approximately 200 nm can be expected to lie between HEC gel concentrations of 0.5 % to 
1 %, as predicted by the Chrambach and Rodbard model. Furthermore, cryo-SEM images 
pointed out, that in general, particles do penetrate hydrogels upon the application of 
external forces, even if the pores are much smaller than the particles. 
This fact revealed two considerable features of the mucus hydrogel which may have an 
impact on particle mobility and penetration in this polymer mesh: pore size distribution in 
conjunction with the thickness of the polymer scaffold. As mentioned above, comparison 
of cryo-SEM images of HEC gels with the results presented in section 6.4.2 showed that 
pore size is not always the limiting factor for penetration. Therefore, considering that 
particles did not penetrate mucus, one would postulate either a high rigidity of the mucin 
scaffold which resists any rupture or deformation upon application of external forces so 
that particles are indeed captured in the smaller pores (if existing) or strong adhesive 
interactions between particles and mucus. The observation of the thick polymer scaffold, a 
very heterogeneous pore size distribution in mucus (which is in accordance with recent 
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findings for cervical mucus (Lai, Wang et al., 2010)) and the fact that mucoinert 
PEGylated particles did not show better penetration into mucus, suggests the former to be 
the dominant mechanism here. The very thick polymer scaffold in mucus (figure 25) may 
be composed of thick mucin bundles as suggested by an earlier study (Lai, Wang et al., 
2010). The consequences of such rigid and thick polymer structure were further assessed in 
section 6.4.4. In summary, to describe mobility of particles in mucus, both size sieving 
effects as well as interaction filtering have to be considered - however only in addition to 
the evaluation of mechanical properties of the polymer scaffold: The results described 
above demonstrate that the key feature of mucus is its highly rigid structure in conjunction 
with the observed heterogeneous pore size distribution of very small but also large pores. 
Assessment of the first point was performed with optical tweezers as advanced tool to 
study active microrheology in a non-invasive way. 
 
 
6.5.4 Optical Tweezers 
The broad distribution of pore size in mucus (section 6.4.3) may be the reason for a broad 
statistical spread of its rheological behavior (figures 26, 28, 29). Particles located in 
smaller pores seem less mobile than particles located in large pores. In any case, however, 
particles in mucus could not be translocated by trapping and the deflection of optical traps.  
Contrary, no comparably large pores exist within HEC gels. This resulted in a much more 
homogeneous material response. Together with relatively small pore sizes, the elastic as 
well as the viscous modulus measured by passive tracking experiments in the setup of 
optical tweezers showed comparable or even bigger values for HEC gels depending on the 
excitation frequency. Active deflection of the beads was, however, possible for HEC gels. 
Thus, while in mucus the MSD may pretend a large spread in particle mobility (with few 
quite mobile particles), macroscopic capillary penetration experiments (see corresponding 
section) and active particle deflection by optical traps challenged this result: In HEC gels, 
particles could be driven actively through the fluid despite the MSD indicating a more 
homogeneous but yet a similar confinement as in mucus. As sketched in figure 31, 
particles in HEC gels are probably dispersed in dense gels of small pore sizes.  
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Figure 31: Particles in HEC hydrogels can be displaced easily by external force fields due to a polymer mesh 
which can be deformed or even ruptured (left). In mucus, particle mobility is determined mainly by the size 
of the respective pore the particle is located in. The rigidity of the mucin scaffold, however, impedes 
displacement of the particle out of such voids (right). 
 
 
The key feature here is that contrary to mucus, upon actively displacing a bead, the 
polymer scaffold of HEC gels may be deformed or even ruptured. In mucus, the mobility 
of particles depends on the local pore size as the encounter of the bead with the wall of the 
respective pore limits its mobility: Due to the polymer scaffold rigidity the beads cannot be 
moved over larger distances. Therefore, the investigation of the microrheology by passive 
particle tracking (measurement of MSD and further processing to calculate rheological 
parameters) must not remain the sole method to extrapolate to particle translocations over 
larger distances. This is particularly true for tracking experiments with very short 
correlation times. It was shown in this study that a setup of optical tweezers is a reliable 
tool not only to determine the microrheology of a material but also auxiliary parameters 
such as pore rigidity and size on the micron scale. 
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6.6 Conclusion 
 
A combination of novel tools such as cryo-SEM, capillary penetration or optical tweezers 
was applied to assess particle mobility in and penetration through mucus and model 
hydrogels on various length scales. It could be shown that the thorough assessment of 
particle penetration through mucus cannot be described solely by methods focusing on 
only one scale, be it micro-, meso-, or macroscopic behavior. It was demonstrated that 
neither adhesive or non-adhesive particle-mucus interactions, nor the pore size of the 
hydrogel alone are sufficient parameters to describe particle mobility in mucus: HEC 
hydrogels with much smaller pore sizes and comparable elastic and viscous modulus were 
even shown to be penetrated more easily by magnetic particles than mucus. It was 
discovered, that this discrepancy may be caused by differences in rigidity of the polymer 
scaffold which was assessed by optical tweezers and a broad pore size distribution in 
mucus. The observed differences in particle mobility due to surface chemistry as described 
in the literature may thus be due to differences in particle adhesion to mucins within larger 
voids of mucus. Therefore, this study presents the so far missing linkage between 
microrheology and macroscopical observations regarding particle mobility in mucus. 
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7. Overall Conclusion and Outlook 
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The presented work illuminates the fate of inhaled material after encountering the mucus 
layer as primary and most important non-cellular component of the air-blood barrier of the 
upper lungs. Here, all main aspects of particle-mucus interactions such as fluid dynamics 
and physical interactions were taken into account, in particular with respect to mucociliary 
clearance and particle mobility in mucus.  
• The identification of possible, yet unknown parameters affecting mucociliary 
clearance was one of the major goals of the presented work. As it is displayed in the 
first section of this study, we could show for the first time to our knowledge that 
particle fate upon deposition as influenced by mucociliary clearance does not 
depend on particle properties such as size, shape, charge and surface chemistry of 
the particles under investigation. This was demonstrated in an ex vivo setup with 
high relevance to the in vivo situation. A lack of relative velocity between 
transported particles and their surrounding medium, the moving mucus blanket, 
was concluded to be the reason for the observed independency on individual 
particle properties. With mucociliary clearance velocity giving indirect evidence for 
particle penetration through mucus, it was hypothesized that particles do not 
sediment upon deposition on an intact and compact mucus layer. Therefore, a 
possible small fraction of particles translocating to the epithelium was considered to 
take advantage of turbulent mucus flow or of heterogeneities in the mucus mesh 
such as larger voids or poorly covered patches of the epithelium. This hypothesis 
was the foundation of the work presented in the second section. 
• Here, mucus fluid dynamics was assessed by analytical and numerical methods. It 
could be confirmed that, indeed, nanoparticles being deposited onto the mucus 
blanket do not sediment or translocate into mucus due to impaction or gravitation. 
This behavior leads to an only negligible time span where a relative velocity 
between mucus and the particles still exists which is however a precondition to 
observe differences in mucociliary clearance. Again, this approach is unique in 
current research and contributed to clarify the fate of particles deposited on the 
mucus blanket. The remaining mechanism potentially susceptible to particle 
properties and thus being able to cause differences in translocation trough the 
mucus blanket is translocation due to turbulent mucus flow, heterogeneous surface 
coverage or collision and spreading of mucus flakes. This was proven feasible in a 
computational approach. Particle diffusion as further mechanism for particle 
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translocation however, so far only considered in a simplified approach in the 
described experiments and calculations, is highly dependent on mucus structure, 
rheology and particle-mucus interactions. Therefore, these parameters needed to be 
additionally investigated as it is shown in the third experimental section. 
• As specified in the aim of the thesis, the parameters mentioned above were 
hypothesized to be crucial factors for particle mobility in mucus. Here, the 
presented unique approach combining macro- and microscopic investigation of 
particle mobility, mucopenetration, mucus structure and rheology revealed several 
key features of mucus inhibiting particle mobility on mesoscopic scales: Contrary 
to chitosan coated particles, PEGylated particles were shown not to adhere to mucin 
fibers. Despite of these, indeed, large differences in adhesive particle-mucus 
interactions, particle penetration through mucus filled capillaries could surprisingly 
not be observed for any particle type, resisting the applied external magnetic field. 
Cryo-SEM analysis of the structure of mucus and HEC gels lead to the following 
conclusion: Mucus heterogeneity in pore size and the thick, possibly rigid, polymer 
scaffold may be the reason for large differences in particle mobility on the 
microscopic scale but impede translocation over larger distances. These postulated 
points were confirmed by experiments involving optical tweezers where active 
deflection of trapped beads revealed that, indeed, even high forces cannot overcome 
the restricting rigid walls of the pores inside mucus. 
In the future, possibilities to overcome this rigid mucus barrier on the individual particle 
level need to be assessed. Here, previous works as presented by Kuhn et al. (Kuhn, 
Hallahan et al., 2006) proposed effective mechanisms such as the degradation of the 
surrounding polymer mesh by enzymes bound to the particles’ surface as highly potential 
delivery system for mucosal surfaces. Furthermore the indirect approach of using particles 
adhesive to the epithelial cells and thus taking advantage of patches of the epithelium 
which are poorly covered with mucus, seems to be suitable to increase the particle 
concentration in the vicinity of the epithelium.  
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